Citations

Citations to this article as recorded by  

• Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
  Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
  Journal of Korean Medical Science.2026;[Epub]     CrossRef
• Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan
  Daisuke Nakamoto, Emi Ohata, Mayumi Yuda, Nobuyuki Fukui, Nao Makino, Rie Kanamori, Nozomi Aoki, Akio Kanazawa, Hirotake Mori, Yuji Nishizaki, Hirohide Yokokawa, Yuichiro Yano, Toshio Naito
  BMC Infectious Diseases.2026;[Epub]     CrossRef
• 2025 KASL clinical practice guidelines for management of hepatitis C
  Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung
  Clinical and Molecular Hepatology.2026; 32(1): 1.     CrossRef
• E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea
  Byeong Geun Song, Myeongcheol Lee, Juhee Cho, Geum-Youn Gwak, Danbee Kang, Dong Hyun Sinn
  Preventive Medicine.2026; 205: 108530.     CrossRef
• Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
  Jiwon Yang, Jihye Lim, Ye‐jee Kim, Hwa Jung Kim, Jonggi Choi
  Journal of Medical Virology.2026;[Epub]     CrossRef
• Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights
  Maria Stella Franzè, Teresa Pollicino, Jean‐Michel Pawlotsky, Vincent Leroy, Giovanni Raimondo, Giuliana Amaddeo
  Liver International.2026;[Epub]     CrossRef
• A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
  Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
  Journal of Hepatology.2025; 82(2): 235.     CrossRef
• Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk in Offspring: A National Cohort Study
  Yewan Park, Jihye Heo, Danbee Kang, Geum‐Youn Gwak
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
  Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee
  Liver International.2025;[Epub]     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission
  Ka Wang Cheung, Ying Rong Li, Ms Tiffany Sin-Tung Au, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103038.     CrossRef
• Effect of invasive tests during pregnancy on perinatal transmission of hepatitis B infection: a scoping review
  Ka Wang Cheung, Tiffany Sin-Tung Au, Ying Rong Li, Zhenyan Han, Zhu Zhang, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103039.     CrossRef
• Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
  Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(1): 131.     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
  Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
  Annals of Medicine.2025;[Epub]     CrossRef
• The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK‐eIF2α‐CHOP‐Mediated ER Stress
  Yu‐Min Choi, Dong Hyun Kim, Eun Ju Cho, Ziyun Kim, Junghwa Jang, Hyunsoo Kim, Su Jong Yu, Bum‐Joon Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
  Hae Lim Lee, Soon Kyu Lee, Ji Won Han, Hyun Yang, Heechul Nam, Pil Soo Sung, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  JHEP Reports.2025; 7(7): 101391.     CrossRef
• Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
  Tyng‐Yuan Jang, Chia‐Yen Dai
  Advances in Digestive Medicine.2025;[Epub]     CrossRef
• Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e161.     CrossRef
• Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
  Chih-Wen Wang, Ming-Lung Yu
  Clinical and Molecular Hepatology.2025; 31(2): 606.     CrossRef
• Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e212.     CrossRef
• Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
  Jihye Lim, Hyundam Gu, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Alzheimer's Research & Therapy.2025;[Epub]     CrossRef
• Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
  Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
  Health Science Reports.2025;[Epub]     CrossRef
• A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
  Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
  Current Hepatology Reports.2025;[Epub]     CrossRef
• A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients
  Shan Ren, Xiao Lin, Wenjing Wang, Wang Xiaoxiao, Lina Ma, Yanhong Zheng, Sujun Zheng, Xinyue Chen
  Hepatology Communications.2025;[Epub]     CrossRef
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2025; 40(7): 1675.     CrossRef
• Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
  Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K
  Journal of Gastroenterology and Hepatology.2025; 40(6): 1595.     CrossRef
• Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
  Jihye Lim, Hyo Young Lee, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B
  Tyng-Yuan Jang, Yu-ting Zeng, Po-Cheng Liang, Chih-Da Wu, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Yi-Shan Tsai, Ming-Yen Hsieh, Yi-Hung Lin, Meng-Hsuan Hsieh, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Batbo
  Journal of the Chinese Medical Association.2025; 88(5): 361.     CrossRef
• Concise Commentary: Gray Area—Underappreciated HCC Risk in Untreated “Gray Zone” and Immune-Tolerant CHB Patients
  Won-Mook Choi
  Digestive Diseases and Sciences.2025; 70(9): 2910.     CrossRef
• Immunizations in adult liver transplant candidates and recipients
  Dongwook Kim, Pyoeng Gyun Choe
  Annals of Liver Transplantation.2025; 5(1): 19.     CrossRef
• Emergency living donor liver transplantation
  Jongman Kim
  Annals of Liver Transplantation.2025; 5(1): 27.     CrossRef
• Association between maternal chronic hepatitis B virus infection and the neurodevelopment of children: A comprehensive Korean cohort study
  Yewan Park, Jihye Heo, Danbee Kang, Geum-Youn Gwak
  Preventive Medicine Reports.2025; 55: 103116.     CrossRef
• Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’. Authors' Reply
  Jiwon Yang, Won‐Mook Choi
  Alimentary Pharmacology & Therapeutics.2025; 62(2): 238.     CrossRef
• Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
  Young Joo Park, Ki Youn Yi, Hyun Young Woo, Jeong Heo, Geun Am Song, Riccardo Nevola
  PLOS One.2025; 20(5): e0324019.     CrossRef
• Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
  Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge
  Annals of Hepatology.2025; 30(2): 101925.     CrossRef
• Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study
  Young Eun Chon, Jonghyun Lee, Eileen L. Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
  European Journal of Gastroenterology & Hepatology.2025;[Epub]     CrossRef
• Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis
  Yuan-Hai Zhou, Nan Cai, Yu-Xin Chen, Yong-Lu Su, Peng Hu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• A Case of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B Who was Not Under Surveillance Following the Loss of HBsAg
  Myeong Jun Song
  The Korean Journal of Gastroenterology.2025; 85(3): 425.     CrossRef
• Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
  Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
  Osteoporosis International.2025; 36(8): 1391.     CrossRef
• Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide vs Entecavir
  Xuan Li, Qiang Wu, Fang Huang, Changxiang Lai, Fengjuan Chen, Juan Meng, Fang Wang, Hui Zeng, Lina Zhang
  PeerJ.2025; 13: e19901.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
• Chronic hepatitis B: Is it time for expanded antiviral treatment?
  Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
  World Journal of Virology.2025;[Epub]     CrossRef
• Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
  Jiwon Yang, Jihye Lim, Ye‐Jee Kim, Hwa Jung Kim, Jonggi Choi
  Liver International.2025;[Epub]     CrossRef
• Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
  Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
  Journal of Gastroenterology and Hepatology.2025; 40(11): 2750.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
• Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study
  Hyun Bin Choi, Jae Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes
  Jung Hyun Kwon, Sung Won Lee, Hee‐Yeon Kim, Do Seon Song, Soon Kyu Lee, Heechul Nam, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study
  Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go
  BMC Infectious Diseases.2025;[Epub]     CrossRef
• Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
  Hyemin Ha, Kwang Il Seo, Nam Kyung Je
  Journal of Infection and Chemotherapy.2025; 31(12): 102860.     CrossRef
• Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
  Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
  Annals of Liver Transplantation.2025; 5(2): 107.     CrossRef
• Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
  Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim
  Gut.2024; 73(4): 649.     CrossRef
• Gray zone of hepatitis B virus infection
  Young-Suk Lim
  Saudi Journal of Gastroenterology.2024; 30(2): 76.     CrossRef
• PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
  Ho Soo Chun, George V. Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L. Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampe
  Journal of Hepatology.2024; 80(1): 20.     CrossRef
• Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
  Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Jonggi Choi
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 515.     CrossRef
• Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
  Liandong Wu, Zhenggang Yang, Min Zheng
  Journal of Viral Hepatitis.2024; 31(5): 255.     CrossRef
• Jaundice That Has Persisted for 5 Days
  Young Chang
  The Korean Journal of Medicine.2024; 99(3): 140.     CrossRef
• Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
  Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
  Diagnostics.2024; 14(5): 495.     CrossRef
• Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
  Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
  OncoTargets and Therapy.2024; Volume 17: 215.     CrossRef
• Linvencovir: Paving the way for functional cure in hepatitis B
  Jiwon Yang, Jonggi Choi
  Clinical and Molecular Hepatology.2024; 30(2): 164.     CrossRef
• Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
  Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
  JHEP Reports.2024; 6(7): 101089.     CrossRef
• Clinical profile and parameters of patients monoinfected with HBV and infected with HDV in Western Amazon
  Eugênia de Castro e Silva, Tárcio Peixoto Roca, Ana Maísa Passos-Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo da Silva Oliveira, Jackson Alves da Silva Queiroz, Juan Miguel Villalobos Salcedo, Deusilene Vieira
  Heliyon.2024; 10(10): e31065.     CrossRef
• Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study
  Laila Kurnia Pramono, Anna Tjandrawati, Dewi Kartika Turbawaty, Tiene Rostini, Muhammad Begawan Bestari, Haryono, Deny Budiman, Prapanca Nugraha, Dirk Uhlmann
  International Journal of Hepatology.2024; 2024: 1.     CrossRef
• Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
  Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
  The Korean Journal of Internal Medicine.2024; 39(4): 577.     CrossRef
• Treatment decisions based on HBV DNA
  Young‐Suk Lim
  Journal of Viral Hepatitis.2024; 31(S2): 36.     CrossRef
• Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
  Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
  Journal of Gastroenterology and Hepatology.2024; 39(11): 2327.     CrossRef
• Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg
  Hye Seon Kim, Jin Seoub Kim, Ji Min Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Liver International.2024; 44(10): 2753.     CrossRef
• Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
  Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
  Clinical and Molecular Hepatology.2024; 30(3): 500.     CrossRef
• Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
  Anadi Mahajan, Saifuddin Kharawala, Supriya Desai, Stuart Kendrick, Joyeta Das, Vera Gielen
  Journal of Viral Hepatitis.2024; 31(11): 746.     CrossRef
• Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
  Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen
  Annals of Internal Medicine.2024; 177(10): 1308.     CrossRef
• Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
  Jeong‐Ju Yoo, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Min Jae Kim
  Journal of the International AIDS Society.2024;[Epub]     CrossRef
• KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
  Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
  Clinical and Molecular Hepatology.2024; 30(Suppl): S5.     CrossRef
• Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
  Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
  Clinical and Molecular Hepatology.2024; 30(Suppl): S159.     CrossRef
• Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
  Jung Hwan Yu
  The Korean Journal of Medicine.2024; 99(5): 232.     CrossRef
• Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
  Yewan Park, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2024; 30(4): 718.     CrossRef
• Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
  Han Ah Lee
  Clinical Ultrasound.2024; 9(2): 70.     CrossRef
• Effect of renin-angiotensin system inhibitor in incident cancer among chronic hepatitis B patients: An emulated target trial using a nationwide cohort
  Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  Journal of the Renin-Angiotensin-Aldosterone System.2024;[Epub]     CrossRef
• Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
  Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
  Infectious Agents and Cancer.2023;[Epub]     CrossRef
• Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
  Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
  European Journal of Gastroenterology & Hepatology.2023; 35(4): 431.     CrossRef
• Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues
  Tyng‐Yuan Jang
  Alimentary Pharmacology & Therapeutics.2023; 57(5): 587.     CrossRef
• The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
  Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(5): 716.     CrossRef
• Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
  Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Frontiers in Oncology.2023;[Epub]     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
• Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
  Moon Haeng Hur, Min Kyung Park, Terry Cheuk-Fung Yip, Chien-Hung Chen, Hyung-Chul Lee, Won-Mook Choi, Seung Up Kim, Young-Suk Lim, Soo Young Park, Grace Lai-Hung Wong, Dong Hyun Sinn, Young-Joo Jin, Sung Eun Kim, Cheng-Yuan Peng, Hyun Phil Shin, Chi-Yi Ch
  American Journal of Gastroenterology.2023; 118(11): 1963.     CrossRef
• Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
  Jeong-Ju Yoo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 513.     CrossRef
• The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
  Moon Haeng Hur, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(2): 363.     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
  Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Hepatology International.2023; 17(4): 860.     CrossRef
• Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
  Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
• Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
  Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
  Diagnostics.2023; 13(9): 1537.     CrossRef
• CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
  Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai‐Hung Wong, Seung Up Kim
  Journal of Digestive Diseases.2023; 24(2): 113.     CrossRef
• Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
  Jihye Kim, Moon Haeng Hur, Seung Up Kim, Jin-Wook Kim, Dong Hyun Sinn, Hyun Woong Lee, Moon Young Kim, Jae Youn Cheong, Yong Jin Jung, Han Ah Lee, Young-Joo Jin, Jun Sik Yoon, Sung-Jae Park, Chang Hun Lee, In Hee Kim, June Sung Lee, Young Youn Cho, Hyung
  Cancers.2023; 15(11): 2936.     CrossRef
• Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
  宇行 刘
  Advances in Clinical Medicine.2023; 13(05): 8702.     CrossRef
• Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
  Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
  BMC Cancer.2023;[Epub]     CrossRef
• Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
  Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
  Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Alimentary Pharmacology & Therapeutics.2023; 58(7): 704.     CrossRef
• The efficacy of treatment for hepatocellular carcinoma in elderly patients
  Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
  Journal of Liver Cancer.2023; 23(2): 362.     CrossRef
• Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia
  Grace Chung‐Yan Lui, Grace Lai‐Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, Sun Hee Lee
  HIV Medicine.2023; 24(10): 1035.     CrossRef
• Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
  Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience
  Sungwon Kim, Sun Woong Kim, Byung Chan Lee, Du Hwan Kim, Duk Hyun Sung
  World Journal of Clinical Cases.2023; 11(32): 7785.     CrossRef
• Hepatocellular carcinoma presenting as organized liver abscess: A case report
  Sung Hyeok Ryou, Hyun Deok Shin, Suk Bae Kim
  World Journal of Clinical Cases.2023; 11(33): 8078.     CrossRef
• The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
  Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
  Diagnostics.2023; 14(1): 14.     CrossRef
• Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
  Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
  Clinical and Molecular Hepatology.2023; 30(1): 49.     CrossRef
• Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
  Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
  Medicine.2023; 102(43): e34276.     CrossRef
• Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
  Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Scientific Reports.2022;[Epub]     CrossRef
• Reply to: “A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations”
  Hyun Yang, Si Hyun Bae, Jeong Won Jang
  Journal of Hepatology.2022; 77(6): 1724.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
• Updated Treatment Guidelines for Chronic Hepatitis B
  Jihyun An
  The Korean Journal of Medicine.2022; 97(6): 353.     CrossRef

Citations

Citations to this article as recorded by  

• Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
  Tyng‐Yuan Jang, Yu‐Ting Zeng, Po‐Cheng Liang, Chih‐Da Wu, Yu‐Ju Wei, Pei‐Chien Tsai, Ming‐Yen Hsieh, Yi‐Hung Lin, Meng‐Hsuan Hsieh, Chih‐Wen Wang, Jeng‐Fu Yang, Ming‐Lun Yeh, Chung‐Feng Huang, Wan‐Long Chuang, Jee‐Fu Huang, Ya‐Yun Cheng, Chia‐Yen Dai, Pau
  Alimentary Pharmacology & Therapeutics.2025; 61(9): 1458.     CrossRef
• Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysis
  Long Huang, Luhuai Feng, Yang Lu, Bobin Hu, Hongqian Liang, Aoli Ren, Hang Wang, Wenming He, Caifang Deng, Minghua Su, Jianning Jiang
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy
  Banri Ogawa, Toshiro Kamoshida, Asaji Yamamoto, Yuji Yamaguchi, Yukako Hamano, Haruka Okawara, Atsushi Okawara, Nobushige Kakinoki, Shinji Hirai
  Internal Medicine.2025; 64(20): 2966.     CrossRef
• Air pollution as a potential risk factor for pancreatic cancer and cholangiocarcinoma in Taiwanese patients
  Tyng‐Yuan Jang, Chi‐Chang Ho, Chih‐Da Wu, Chia‐Yen Dai, Pau‐chung Chen
  Advances in Digestive Medicine.2025;[Epub]     CrossRef
• MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response
  Haimei Chen, Jie Zhu, Jinhui Zhou, Ziying Yin, Jun Chen, Sudhakar K. Venkatesh, Meng Yin, Richard L. Ehman, Jin Wang
  European Radiology.2025; 35(12): 8032.     CrossRef
• Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
  Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Wo
  Clinical and Molecular Hepatology.2025; 31(3): 810.     CrossRef
• Long-Term Safety and Efficacy of Tenofovir Alafenamide in Chronic Hepatitis B: Raising the Need for Studies on Functional Cure—Editorial on “Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B”
  Soon Kyu Lee
  The Korean Journal of Gastroenterology.2025; 85(3): 245.     CrossRef
• Single-nucleotide polymorphisms in CYP27B1 and VDR genes associated with treatment outcomes in hepatitis B and C: A minireview
  Alessandra Ramalho Correia, Victor Cavicchioli, Lara Cândida de Sousa Machado, Rahisa Scussel, Ricardo Andrez Machado-de-Ávila, Iane de Oliveira Pires Porto, Iara Barreto Neves Oliveira
  Pharmacological Research - Reports.2025; 4: 100061.     CrossRef
• Interferon-based optimal antiviral strategies in underage patients with chronic hepatitis B: A propensity score-weighted cohort study
  Limin Wang, Meina Li, Yi Dong, Xiaofang Yu, Jing Chen, Yaojie Kang, Weiwei Liu, Pan Zhao
  International Journal of Antimicrobial Agents.2025; 66(6): 107618.     CrossRef
• Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
  Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Factors associated with hepatitis B mother-to-child transmission in a national prevention program
  Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
  Clinical and Molecular Hepatology.2025; 31(4): 1298.     CrossRef
• Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
  Jie Li, Meng Li, Hui Sun, Yan-Ting Yu, Yu-Hang Zhou, Fei Fu, Lei Yan
  World Journal of Gastrointestinal Surgery.2025;[Epub]     CrossRef
• Development and Validation of an Extra Spindle Pole Bodies–like 1–Based Diagnostic and Prognostic Model for Hepatitis B Virus–Related Hepatocellular Carcinoma: Retrospective Cohort Study
  Lu-Huai Feng, Hengkai Liang, Bobin Hu, Lu Wei, Qingmei Li, Tumei Su, Qianbing Yin, Yanfei Feng, Long Huang, Hongqian Liang, Minghua Su, Jianning Jiang
  JMIR Medical Informatics.2025; 13: e78354.     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
  Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L. Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
  The Kaohsiung Journal of Medical Sciences.2024; 40(2): 188.     CrossRef
• Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma
  Won Tae Cho, Tae Yoo, Jung Min Lee, Jung Woo Lee, Hanbaro Kim, Ji Soo Lee, Sang Hyup Han
  Journal of Surgical Research.2024; 295: 231.     CrossRef
• The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
  Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang
  Journal of Korean Medical Science.2024;[Epub]     CrossRef
• Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
  Malgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, Michele Bartoletti, Anna Maria Frustaci, Andrea Visentin, Candida Vitale, Francesca R. Mauro
  Blood Reviews.2024; 65: 101180.     CrossRef
• Air pollution as a potential risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
  Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
  Journal of the Chinese Medical Association.2024; 87(3): 287.     CrossRef
• Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy
  Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon
  Cancers.2024; 16(5): 887.     CrossRef
• Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
  Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
  Diagnostics.2024; 14(5): 495.     CrossRef
• Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
  Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, Jang Han Jung, Hidenori Toyoda, Chih‐Wen Wang, Man‐Fung Yuen, Ka Shing Cheung, Satoshi Yasuda, Sung Eun Kim, Eileen L Yoon, Jihyun An, Masaru Enomoto, Ritsuzo Kozuka, Makoto Chuma, Akito Nozaki, Toru Ishikawa,
  Journal of Gastroenterology and Hepatology.2024; 39(6): 1190.     CrossRef
• Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
  Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
  Gut and Liver.2024; 18(2): 305.     CrossRef
• Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
  Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
  Journal of Gastroenterology and Hepatology.2024; 39(8): 1673.     CrossRef
• How Does Chronic Hepatitis B Infection Impact on Severity of COVID-19 Infection?
  Behnaz Khodabakhshi, Mahdi Mazandarani, Narges Lashkarbolouk, Mehrnaz Razzazan, Khadije Amjadi
  International Journal of Infection.2024;[Epub]     CrossRef
• Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
  Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
  PLOS ONE.2024; 19(8): e0307712.     CrossRef
• Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study
  Nicoleta Mihai, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, Victoria Aramă
  Journal of Clinical Medicine.2024; 13(20): 6032.     CrossRef
• Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis
  Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
  Clinical and Molecular Hepatology.2024; 30(Suppl): S106.     CrossRef
• Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
  Wei-Chun Lin, Ke Lin, Ming-Kai Li, Xiao Liu, Yi-Fei Huang, Xing Wang, Bin Wu
  World Journal of Hepatology.2024; 16(11): 1321.     CrossRef
• Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals
  Soo Young Hwang, Sung Hwan Yoo, Hye Young Chang, Sora Kim, Jung Il Lee, Kwan Sik Lee, Young Youn Cho, Kim Hyung Joon, Hyun Woong Lee
  Journal of Viral Hepatitis.2023; 30(1): 39.     CrossRef
• Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
  Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
  Hepatology Communications.2023; 7(2): e0011.     CrossRef
• The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
  Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(5): 716.     CrossRef
• Low Level of Hepatitis B Viremia Compared With Undetectable Viremia Increases the Risk of Hepatocellular Carcinoma in Patients With Untreated Compensated Cirrhosis
  Jiwon Yang, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
  American Journal of Gastroenterology.2023; 118(6): 1010.     CrossRef
• Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients
  Woo‐Hyoung Kang, Shin Hwang, Masaki Kaibori, Jong Man Kim, Kyung Sik Kim, Tsuyoshi Kobayashi, Hiroto Kayashima, Yang Seok Koh, Keiichi Kubota, Akira Mori, Yutaka Takeda, Sung Su Yun, Kousuke Matsui, Kan Toriguchi, Hiroaki Nagano, Myung Hee Yoon, Yuji Soej
  Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(8): 993.     CrossRef
• Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study
  Sujin Gang, YoungRok Choi, Boram Lee, Kyung Chul Yoon, Su young Hong, Sanggyun Suh, Eui Soo Han, Suk Kyun Hong, Hae Won Lee, Jai Young Cho, Nam-joon Yi, Kwang-Woong Lee, Kyung-Suk Suh
  Annals of Surgical Treatment and Research.2023; 104(4): 183.     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
  Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
• Research Progress on the Need for Antiviral Therapy in Chronic HBV Infected Patients with Normal ALT
  益帆 胡
  Advances in Clinical Medicine.2023; 13(04): 5360.     CrossRef
• Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis
  David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Nikolaos Pyrsopoulos, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(8): 1372.     CrossRef
• Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
  Joo Hyun Oh, Yewan Park, Myung Ji Goh, Dong Hyun Sinn, Sang Bong Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
  Scientific Reports.2023;[Epub]     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
  Jonggi Choi, Won-Mook Choi, Young-Suk Lim
  Clinics in Liver Disease.2023; 27(4): 809.     CrossRef
• Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
  Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  World Journal of Gastroenterology.2023; 29(24): 3843.     CrossRef
• KASL clinical practice guidelines for management of autoimmune hepatitis 2022
  
  Clinical and Molecular Hepatology.2023; 29(3): 542.     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
  Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef
• Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients
  Yeonjung Ha, Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Seong Gyu Hwang, Seungbong Han, Han Chu Lee
  International Journal of Cancer.2023; 153(12): 2045.     CrossRef
• The Effect of Entecavir and Tenofovir Disoproxil on Bone Mineral Density in Chronic Hepatitis B Treatment
  Yasemin EMÜR GÜNAY, Arif Mansur COŞAR
  Journal of Contemporary Medicine.2023; 13(5): 1013.     CrossRef
• Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
  Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
  Infectious Diseases and Therapy.2023; 12(10): 2387.     CrossRef
• Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
  Soo Ryang Kim, Soo Ki Kim
  Diagnostics.2023; 13(20): 3212.     CrossRef
• Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
  Cesar Henriquez-Camacho, Ana Isabel Hijas-Gomez, Carlos Risco Risco, Maria Angeles Ruiz Lapuente, Rosa Escudero-Sanchez, Victor Moreno Cuerda
  Viruses.2023; 15(11): 2241.     CrossRef
• A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus
  Marina Manea, Dimitri Apostol, Ileana Constantinescu
  Diagnostics.2023; 13(22): 3425.     CrossRef
• Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance
  Saein Kim, Sunghwan Yoo, Jung Il Lee, Sora Kim, Hye Young Chang, Dokyun Kim, Seok Hoon Jeong, Kwan Sik Lee, Hyun Woong Lee
  Digestive Diseases and Sciences.2022; 67(1): 321.     CrossRef
• Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
  Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
• Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis B
  Chan-Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  Clinical Gastroenterology and Hepatology.2022; 20(4): 956.     CrossRef
• Long‐term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
  Young Eun Chon, Seung Up Kim, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, Yun Ho Roh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Soo Young Park, Beom Kyung Kim
  Journal of Gastroenterology and Hepatology.2022; 37(1): 200.     CrossRef
• Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
  Myung Ji Goh, Wonseok Kang, Kwang Min Kim, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Scandinavian Journal of Gastroenterology.2022; 57(1): 70.     CrossRef
• Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
  Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
  Annals of the Rheumatic Diseases.2022; 81(4): 584.     CrossRef
• Clinical Outcomes of Hepatitis B Virus–Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels
  Jong-In Chang, Dong Hyun Sinn, Hyun Cho, Seonwoo Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Digestive Diseases and Sciences.2022; 67(9): 4565.     CrossRef
• Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas
  Jihyun An, Deokhoon Kim, Bora Oh, Yoo‐Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji‐Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi‐Won Song, Dae‐Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman‐Rossi, Han Chu Lee, Ju Hyun Shim
  Hepatology.2022; 75(4): 997.     CrossRef
• Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients
  Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jae Young Jang, Dong Joon Kim, Eun‐Sook Park, So‐Young Jin, Kyun‐Hwan Kim
  Journal of Gastroenterology and Hepatology.2022; 37(2): 378.     CrossRef
• On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
  Chung‐Feng Huang, Tyng‐Yuan Jang, Dae Won Jun, Sang Bong Ahn, Jihyun An, Masaru Enomoto, Hirokazu Takahashi, Eiichi Ogawa, Eileen Yoon, Soung Won Jeong, Jae‐Jun Shim, Jae Yoon Jeong, Sung Eun Kim, Hyunwoo Oh, Hyoung Su Kim, Yong Kyun Cho, Ritsuzo Kozuka,
  Liver International.2022; 42(1): 59.     CrossRef
• Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B
  Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Digestive Diseases and Sciences.2022; 67(7): 3412.     CrossRef
• Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study
  Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  BMC Medicine.2022;[Epub]     CrossRef
• Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient
  Jong Chul Kim, Hye Young Lee, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Juhee Won, Soree Park, Na Yeon Kim, Jae Jin Shin, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo, Kyun-Hwan Kim
  Biomedicines.2022; 10(2): 282.     CrossRef
• Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
  Ben Kang, Dae Yong Yi, Byung-Ho Choe
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
  Young‐Suk Lim, Wai‐Kay Seto, Masayuki Kurosaki, Scott Fung, Jia‐Horng Kao, Jinlin Hou, Stuart C. Gordon, John F. Flaherty, Leland J. Yee, Yang Zhao, Kosh Agarwal, Pietro Lampertico
  Alimentary Pharmacology & Therapeutics.2022; 55(8): 921.     CrossRef
• Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
  Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2022; 29(4): 289.     CrossRef
• Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
  Chan‐Young Jung, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  Liver International.2022; 42(5): 1017.     CrossRef
• Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
  Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Hepatology.2022; 76(2): 492.     CrossRef
• Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis
  Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
  BMC Gastroenterology.2022;[Epub]     CrossRef
• A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study
  Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei
  BMC Cancer.2022;[Epub]     CrossRef
• A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
  Hyun Yang, Si Hyun Bae, Heechul Nam, Hae Lim Lee, Sung Won Lee, Sun Hong Yoo, Myeong Jun Song, Jung Hyun Kwon, Soon Woo Nam, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Journal of Hepatology.2022; 77(3): 632.     CrossRef
• Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
  Young Mi Hong, Ki Tae Yoon
  The Korean Journal of Gastroenterology.2022; 79(4): 156.     CrossRef
• Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
  Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim, Homie Razavi, Devin Razavi‐Shearer, Dong Hyun Sinn
  Alimentary Pharmacology & Therapeutics.2022; 56(3): 519.     CrossRef
• Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
  Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young-Suk Lim
  Journal of Clinical Investigation.2022;[Epub]     CrossRef
• Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
  Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
  Journal of Viral Hepatitis.2022; 29(9): 756.     CrossRef
• Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir
  Juhee Won, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Jong Chul Kim, Soree Park, Nayeon Kim, Byengjune Jae, Kyun-Hwan Kim
  Biomedicines.2022; 10(7): 1637.     CrossRef
• Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2022; 103: 122.     CrossRef
• Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure
  Xiao Lin, Aixin Song, Junfeng Lu, Sujun Zheng, Zhongjie Hu, Lina Ma, Zhenhuan Cao, Hong Li, Yanhong Zheng, Shan Ren, Xinyue Chen
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
  Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
  Clinical and Molecular Hepatology.2022; 28(3): 425.     CrossRef
• The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
  Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
  Clinical and Molecular Hepatology.2022; 28(3): 351.     CrossRef
• Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
  Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
  Abdominal Radiology.2022; 47(11): 3733.     CrossRef
• Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
  Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong
  Gut and Liver.2022; 16(4): 567.     CrossRef
• Correlation between hepatic venous pressure gradient and portal venous pressure gradient in hepatitis B cirrhosis with different hepatic veins anatomy
  Yifan Lv, Qingkun Song, Zhendong Yue, Hongwei Zhao, Lei Wang, Zhenhua Fan, Yifan Wu, Mingming Meng, Ke Zhang, Li Jiang, Huiguo Ding, Yuening Zhang, Fuquan Liu
  European Journal of Radiology.2022; 155: 110463.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
  Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
  Journal of Clinical Medicine.2022; 11(22): 6613.     CrossRef
• Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
  Xiao Lin, Yanhong Zheng, Hong Li, Junfeng Lu, Shan Ren, Yisi Liu, Xiaoxiao Wang, Sujun Zheng, Lina Ma, Zhenhuan Cao, Xinyue Chen
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
  Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
  Drug Design, Development and Therapy.2022; Volume 16: 3263.     CrossRef
• Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma
  Kwang-Il Seo, Jae-Cheol Jo, Da-Jung Kim, Jee-Yeong Jeong, Sangjin Lee, Ho-Sup Lee
  Viruses.2022; 14(9): 1943.     CrossRef
• Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B
  Chan‐Young Jung, Hyung Woo Kim, Jung Il Lee, Hyun Woong Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  Liver International.2022; 42(11): 2408.     CrossRef
• Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
  Joo Hyun Oh, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun, Sang Bong Ahn
  Journal of Personalized Medicine.2022; 12(12): 1957.     CrossRef
• Updated Treatment Guidelines for Chronic Hepatitis B
  Jihyun An
  The Korean Journal of Medicine.2022; 97(6): 353.     CrossRef
• A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab
  Xiangjuan Guo, Tongtong Ji, Shengliang Xin, Jinghang Xu, Yanyan Yu
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Report on the External Quality Assessment Scheme for Molecular Microbiology, Hepatitis Virus 1, 2 (2016–2021)
  Hee-Won Moon, Tae Hwan Lee, Jong Do Seo
  Journal of Laboratory Medicine and Quality Assurance.2022; 44(4): 191.     CrossRef
• Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
  Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  Digestive Diseases and Sciences.2021; 66(8): 2816.     CrossRef
• Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection
  Jonggi Choi, Chanyoung Jo, Young‐Suk Lim
  Hepatology.2021; 73(2): 661.     CrossRef
• Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B
  Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Jeong Won Jang, Heechul Nam, Kyoung Won Baik, Sun Hong Yoo, Soon Woo Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
  Liver International.2021; 41(2): 288.     CrossRef
• Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B
  Hye-Lin Kim, Gi-Ae Kim, Jae-A Park, Hye-Rim Kang, Eui-Kyung Lee, Young-Suk Lim
  Gut.2021; 70(11): 2172.     CrossRef
• Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
  Hye Won Lee, Young Eun Chon, Beom Kyung Kim, Terry Cheuk-Fung Yip, Yee-Kit Tse, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sang Hoon Ahn
  European Journal of Internal Medicine.2021; 84: 68.     CrossRef
• Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
  Jonggi Choi, Young‐Suk Lim
  The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262.     CrossRef
• Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
  Young Eun Ahn, Sang Jun Suh, Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
  The Korean Journal of Gastroenterology.2021; 77(1): 22.     CrossRef
• Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
  Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Clinical and Translational Gastroenterology.2021; 12(1): e00290.     CrossRef
• Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B
  Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim
  Journal of Viral Hepatitis.2021; 28(10): 1362.     CrossRef
• Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
  Xinhe Zhang, Lin Guan, Haoyu Tian, Zilu Zeng, Jiayu Chen, Die Huang, Ji Sun, Jiaqi Guo, Huipeng Cui, Yiling Li
  Frontiers in Oncology.2021;[Epub]     CrossRef
• The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
  Minah Kim, Yeonju Lee, Jun Sik Yoon, Minjong Lee, So Shin Kye, Sun Woong Kim, Yuri Cho
  Cancers.2021; 13(10): 2301.     CrossRef
• The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
• Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
  Jeong Eun Song, Jun Yong Park
  Expert Opinion on Pharmacotherapy.2021; 22(18): 2427.     CrossRef
• Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
  Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
  Journal of Clinical Medicine.2021; 10(11): 2320.     CrossRef
• Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea
  Young Cheol Ju, Dae Won Jun, Eileen L. Yoon, Sang Bong Ahn, Yun Jin Kim, Mindie H. Nguyen
  Journal of Clinical Medicine.2021; 10(20): 4633.     CrossRef
• External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
  Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
• Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir
  Xiaomo Wang, Yu Chen, Manman Xu, Kailiang Cheng, Xiaoman Duan, Wei Liao, Yanhong Wang, Ying Lu, Zhongping Duan, Li Wang
  Expert Review of Gastroenterology & Hepatology.2021; 15(11): 1337.     CrossRef
• Twelve‐month post‐treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B
  Sang Bong Ahn, Jun Choi, Dae Won Jun, Hyunwoo Oh, Eileen L. Yoon, Hyoung Su Kim, Soung Won Jeong, Sung Eun Kim, Jae‐Jun Shim, Yong Kyun Cho, Hyo Young Lee, Sung Won Han, Mindie H. Nguyen
  Liver International.2021; 41(7): 1652.     CrossRef
• Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
  Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
  Clinical and Translational Gastroenterology.2021; 12(2): e00299.     CrossRef
• Association between HBs Ag quantification and the risk of hepatocellular carcinoma in patients treated with tenofovir disoproxil fumarate or entecavir
  Jung Hyun Lim, Jung Hwan Yu, Young Ju Suh, Jin-Woo Lee, Young-Joo Jin
  Medicine.2021; 100(39): e27417.     CrossRef
• Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma
  Soon Kyu Lee, Pil Soo Sung, Sung-Soo Park, Chang-Ki Min, Heechul Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
  Clinical Infectious Diseases.2021; 73(6): e1372.     CrossRef
• Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B
  Yeonsoo Jang, Sang Hoon Ahn, Kyunghwa Lee, Oh Young Kwon, Jeong Hyun Kim
  International Journal of Environmental Research and Public Health.2021; 18(21): 11139.     CrossRef
• Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC
  Hyo Jung Cho, Geum Ok Baek, Moon Gyeong Yoon, Hye Ri Ahn, Ju A Son, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
  Diagnostics.2021; 11(7): 1221.     CrossRef
• Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
  Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
  Journal of Personalized Medicine.2021; 11(4): 267.     CrossRef
• Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
  Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  Hepatology International.2021; 15(4): 892.     CrossRef
• Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
  Sung Won Lee, Sung Min Kim, Wonhee Hur, Byung-Yoon Kang, Hae Lim Lee, Heechul Nam, Sun Hong Yoo, Pil Soo Sung, Jung Hyun Kwon, Jeong Won Jang, Seong-Jun Kim, Seung Kew Yoon, Partha Mukhopadhyay
  PLOS ONE.2021; 16(12): e0261067.     CrossRef
• Reply to “Emergent liver transplantation for patients with acute-on-chronic liver failure”
  Ji Eun Kim, Dong Hyun Sinn, Gyu-Seong Choi
  Digestive and Liver Disease.2021; 53(10): 1361.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef
• Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
  Young-Hwan Ahn, Heirim Lee, Do Young Kim, Hye Won Lee, Su Jong Yu, Young Youn Cho, Jeong Won Jang, Byoung Kuk Jang, Chang Wook Kim, Hee Yeon Kim, Hana Park, Hyo Jung Cho, Bumhee Park, Soon Sun Kim, Jae Youn Cheong
  Gut and Liver.2021; 15(3): 410.     CrossRef
• Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
  Jihye Lim, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Han Chu Lee, Yeonjung Ha
  Cancers.2021; 13(22): 5609.     CrossRef
• Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
  Ji Eun Na, Dong Hyun Sinn, Jeong‐Hoon Lee, Hee Joon Jang, Seon Yeong Baek, Kyung A Kim, Won Seok Kang, Geum‐Youn Gwak, Young‐Han Paik, Yoon Jun Kim, Moon Seok Choi, Jung‐Hwan Yoon, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Journal of Viral Hepatitis.2021; 28(10): 1392.     CrossRef
• Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy
  Seogsong Jeong, Yuri Cho, Sang Min Park, Won Kim
  Journal of Clinical Gastroenterology.2021; 55(9): e77.     CrossRef
• Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B
  Do Seon Song, Jeong Won Jang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
  Clinical Infectious Diseases.2021; 73(4): e892.     CrossRef
• Association of Metabolic Risk Factors With Risks of Cancer and All‐Cause Mortality in Patients With Chronic Hepatitis B
  Yun Bin Lee, Hyemi Moon, Jeong‐Hoon Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Fabien Zoulim, Juneyoung Lee, Jung‐Hwan Yoon
  Hepatology.2021; 73(6): 2266.     CrossRef
• The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus–related hepatocellular carcinoma
  Ji Hyun Lee, Beom Kyung Kim, Soo Young Park, Won Young Tak, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Dong Hyun Sinn, Seung Up Kim
  European Journal of Internal Medicine.2021; 89: 48.     CrossRef
• Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Hepatology International.2021; 15(5): 1083.     CrossRef
• Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
  Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
  Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
• Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection
  Dmitry V. Garbuzenko
  Medical Journal of the Russian Federation.2021; 27(4): 373.     CrossRef
• Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
  Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo
  Clinical Gastroenterology and Hepatology.2020; 18(3): 693.     CrossRef
• Reply to: “Comment on – A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea”
  Beom Kyung Kim
  Journal of Hepatology.2020; 72(1): 198.     CrossRef
• Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy
  Chung Gyo Seo, Sun Young Yim, Soon Ho Um, Yoo Ra Lee, Yoo Jin Lee, Tae Hyung Kim, Hyun Gil Goh, Young Sun Lee, Sang Jun Suh, Na Yeon Han, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Hyung Joon Yim, Ji Hoon Kim, Dong Sik Kim, Yoon Tae Jeen, Hoon
  Clinics and Research in Hepatology and Gastroenterology.2020; 44(4): 532.     CrossRef
• Kidney disease in patients with chronic liver disease
  Jae Hyun Chang
  Journal of the Korean Medical Association.2020; 63(1): 14.     CrossRef
• Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
  Hyo Cho, Jung Eun, Geum Baek, Chul Seo, Hye Ahn, Soon Kim, Sung Cho, Jae Cheong
  Journal of Clinical Medicine.2020; 9(1): 281.     CrossRef
• Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen‐negative, core antibody‐positive recipients
  Jihye Kim, Se Jin Chung, Dong Hyun Sinn, Kyo Won Lee, Jae Berm Park, Wooseong Huh, Jung Eun Lee, Hye Ryoun Jang, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Journal of Viral Hepatitis.2020; 27(7): 739.     CrossRef
• Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
  Yeon Woo Jung, Moonhyun Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
  Emilia Hadziyannis, Stephanos Hadziyannis
  Expert Review of Gastroenterology & Hepatology.2020; 14(4): 243.     CrossRef
• Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
  Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
  Journal of Gastroenterology and Hepatology.2020; 35(11): 1960.     CrossRef
• Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
  Gi‐Ae Kim, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, Young‐Suk Lim
  Alimentary Pharmacology & Therapeutics.2020; 51(11): 1169.     CrossRef
• Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance
  Hyun Woong Lee, Jung Il Lee, Saein Kim, Sora Kim, Hye Young Chang, Kwan Sik Lee
  BMC Gastroenterology.2020;[Epub]     CrossRef
• An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
  Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
  Liver International.2020; 40(7): 1736.     CrossRef
• Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply
  Gi‐Ae Kim, Young‐Suk Lim
  Alimentary Pharmacology & Therapeutics.2020; 51(12): 1440.     CrossRef
• Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase
  Han Ah Lee, Hyun Woong Lee, In Hee Kim, Soo Young Park, Dong Hyun Sinn, Jung Hwan Yu, Yeon Seok Seo, Soon Ho Um, Jung Il Lee, Kwan Sik Lee, Chang Hun Lee, Won Young Tak, Young Oh Kweon, Wonseok Kang, Yong‐Han Paik, Jin‐Woo Lee, Sang Jun Suh, Young Kul Jun
  Alimentary Pharmacology & Therapeutics.2020; 52(1): 196.     CrossRef
• Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir
  Tae Seop Lim, Hyun Woong Lee, Jung Il Lee, In Hee Kim, Chang Hun Lee, Byoung Kuk Jang, Woo Jin Chung, Hyung Joon Yim, Sang Jun Suh, Yeon Seok Seo, Han Ah Lee, Jung Hwan Yu, Jin‐Woo Lee, Sang Gyune Kim, Young Seok Kim, Soo Young Park, Won Young Tak, Soon S
  Journal of Viral Hepatitis.2020; 27(10): 1052.     CrossRef
• Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
  Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim
  Journal of Viral Hepatitis.2020; 27(9): 932.     CrossRef
• High body mass index hinders fibrosis improvement in patients receiving long‐term tenofovir therapy in hepatitis B virus‐related cirrhosis
  Young Eun Chon, Kyu Sik Jung, Yeonjung Ha, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang, Sang Hoon Ahn, Do Young Kim, Kwang‐Hyub Han, Jun Yong Park
  Journal of Viral Hepatitis.2020; 27(11): 1119.     CrossRef
• Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
  Byoung Kuk Jang
  Clinical and Molecular Hepatology.2020; 26(3): 312.     CrossRef
• Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
  Hyung Joon Yim, Won Kim, Sang Hoon Ahn, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Young Kul Jung, Soon Ho Um, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Byung Seok Lee, Ju Hyun Kim, Hong Soo Ki
  American Journal of Gastroenterology.2020; 115(8): 1217.     CrossRef
• Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B
  Kyung Hyun Kim, Dong Jin Joo, Yong-ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
  Digestive and Liver Disease.2020; 52(11): 1338.     CrossRef
• Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients
  Zhong Fang, Xiaoyu Yu, Shuangmei Tong, Chuan Lu, Yuxian Huang, Liang Chen, Zhenghong Yuan, Yi Zhang
  Clinical Immunology.2020; 219: 108570.     CrossRef
• Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
  Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
  Scientific Reports.2020;[Epub]     CrossRef
• Editorial: comorbidities in patients with chronic hepatitis B—authors' reply
  Eileen L. Yoon, Hyunwoo Oh, Dae Won Jun, Mindie H. Nguyen
  Alimentary Pharmacology & Therapeutics.2020; 52(5): 893.     CrossRef
• A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
  Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2020; 27(12): 1352.     CrossRef
• THERAPEUTIC PLASMAPHERESIS IN A COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS
  Vladislav V. Lyubchak, Viktoriia M. Plaksa, Ihor M. Pelo, Michael P. Kovalishyn, Viktor P. Lyubchak, Vladimir V. Horokh, Tetyana Iu. Lisovenko, Viktoriia V. Ilyina, Liliya M. Khomenko
  Wiadomości Lekarskie.2020; 73(7): 1454.     CrossRef

• Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

  
  Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2020; Volume 7: 403.     CrossRef
• Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
  Tung‐Hung Su, Jia‐Horng Kao
  Clinical Liver Disease.2020; 16(6): 244.     CrossRef
• Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients
  Daniel E Dulek, Robert C Fuhlbrigge, Alison C Tribble, James A Connelly, Michele M Loi, Hassan El Chebib, Shanmuganathan Chandrakasan, William R Otto, Caroline Diorio, Garrett Keim, Kelly Walkovich, Preeti Jaggi, Jennifer E Girotto, April Yarbrough, Edwar
  Journal of the Pediatric Infectious Diseases Society.2020; 9(6): 716.     CrossRef
• Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
  Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
  Clinical and Translational Gastroenterology.2020; 11(3): e00140.     CrossRef
• Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
  Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Ju Lee, Hye Jung Shin, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
  Cancer Epidemiology, Biomarkers & Prevention.2020; 29(4): 832.     CrossRef
• Reply to: “Comparison of risk of hepatocellular carcinoma between tenofovir and entecavir: One direction or no direction”
  Beom Kyung Kim
  Journal of Hepatology.2019; 71(4): 847.     CrossRef
• New Potential Therapies for Chronic Hepatitis B
  Sun Hong Yoo, Jung Hyun Kwon
  The Korean Journal of Gastroenterology.2019; 74(5): 267.     CrossRef
• Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
  Hyun Woong Lee
  The Korean Journal of Gastroenterology.2019; 74(5): 251.     CrossRef
• Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
  Eileen L. Yoon
  The Korean Journal of Gastroenterology.2019; 74(5): 258.     CrossRef
• Natural History and Treatment Indications of Chronic Hepatitis B
  Dong Hyun Sinn
  The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef

Citations

Citations to this article as recorded by  

• Factors associated with hepatitis B mother-to-child transmission in a national prevention program
  Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
  Clinical and Molecular Hepatology.2025; 31(4): 1298.     CrossRef
• Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
  Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
• Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea
  Hyun Deok Shin, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Hyuk Soo Eun, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Seok Hwan Kim, Myung Joon Song, Soon Yeong Ko, Suk Bae Kim
  The Korean Journal of Gastroenterology.2024; 83(3): 111.     CrossRef
• Non-Invasive Monitoring of the Impact of Low-Level Viremia on Liver Fibrosis in Treated Chronic Hepatitis B Patients
  Jinxian Xu, Yang Zhang, Lujian Zhu, Shiyue Tang, Hanglu Xu, Dehe Zhang, Haijun Chen, Jing Zhou
  Infection and Drug Resistance.2024; Volume 17: 2751.     CrossRef
• Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
  Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
  PLOS ONE.2024; 19(8): e0307712.     CrossRef
• Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
  Su Jong Yu, Jeong-Ju Yoo, Dong Ho Lee, Su Jin Kim, Eun Ju Cho, Se Hyung Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jeong Min Lee, Jae Young Lee, Jung-Hwan Yoon
  Biomedicines.2023; 11(2): 382.     CrossRef
• Occurrence of Liver Cancer in People without Traditional Risk Factors
  Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
  Korean Journal of Clinical Geriatrics.2023; 24(1): 41.     CrossRef
• Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score
  Min Kyung Park, Dong Ho Lee, Bo Yun Hur, Hyung-Chul Lee, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
  Radiology.2023;[Epub]     CrossRef
• Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
  Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
  Gyeol Seong, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  European Journal of Gastroenterology & Hepatology.2022; 34(1): 69.     CrossRef
• External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2022; 14(3): 711.     CrossRef
• Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
  Sun Yoo, Ji Yoon Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi
  Journal of Hepatology.2022; 77(4): 939.     CrossRef
• Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
  Min-Jae Kim, Woo-Hyoung Kang, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
  Journal of Clinical Medicine.2022; 11(19): 5897.     CrossRef
• Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers
  Jung Hun Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo, Eileen L. Yoon, Seong Hee Kang
  Antimicrobial Agents and Chemotherapy.2022;[Epub]     CrossRef
• Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
  Eun-Ji Choi, Young-Joon Kim
  Journal of Liver Cancer.2022; 22(2): 103.     CrossRef
• Risk stratification of primary liver cancer
  You-Wen Tan
  World Journal of Clinical Cases.2022; 10(26): 9545.     CrossRef
• Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis
  Xiangbo Meng, Zhengqi Pan, Jiawei Zhao, Quansheng Feng
  Medicine.2022; 101(46): e31664.     CrossRef
• Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study
  Jeong-Hoon Lee, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
  Clinical Infectious Diseases.2021; 73(9): e3308.     CrossRef
• Absence of association between pretransplant serum soluble programmed death protein-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma
  Byeong-Gon Na, Yun Kyu Kim, Shin Hwang, Kyung Jin Lee, Gil-Chun Park, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Hunji Yang, Young-In Yoon, Eunyoung Tak, Yo-Han Park, Sung-Gyu Lee
  Medicine.2021; 100(17): e25640.     CrossRef
• Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
  Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  Hepatology International.2021; 15(4): 892.     CrossRef
• Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
  Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
  Hepatology International.2021; 15(6): 1328.     CrossRef
• S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
  Markus Cornberg, Lisa Sandmann, Ulrike Protzer, Claus Niederau, Frank Tacke, Thomas Berg, Dieter Glebe, Wolfgang Jilg, Heiner Wedemeyer, Stefan Wirth, Christoph Höner zu Siederdissen, Petra Lynen-Jansen, Pia van Leeuwen, Jörg Petersen
  Zeitschrift für Gastroenterologie.2021; 59(07): 691.     CrossRef
• Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
  Han Ah Lee, Young-Sun Lee, Beom Kyung Kim, Young Kul Jung, Seung Up Kim, Jun Yong Park, Ji Hoon Kim, Hyunggin An, Do Young Kim, Hyung Joon Yim, Sang Hoon Ahn, Jong Eun Yeon, Kwan Soo Byun, Kwang-Hyub Han, Soon Ho Um, Yeon Seok Seo
  Gut and Liver.2021; 15(3): 420.     CrossRef
• Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
  Hye Yeon Chon, Jae Seung Lee, Hye Won Lee, Ho Soo Chun, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Hepatology Research.2021; 51(4): 406.     CrossRef
• Prevalence of hepatitis B and C viral markers among apparently healthy residents of the Socialist Republic of Vietnam (Southern Vietnam)
  Yu. V. Ostankova, A. V. Semenov, E. B. Zueva, E. N. Serikova, A. N. Schemelev, D. E. Valutite, H. K.T. Huinh, S. A. Egorova, A. A. Totolian
  Russian Journal of Infection and Immunity.2021; 11(6): 1131.     CrossRef
• Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
  Hankil Lee, Beom Kyung Kim, Sungin Jang, Sang Hoon Ahn
  Clinical and Translational Gastroenterology.2021; 12(2): e00299.     CrossRef
• Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation
  Shin Hwang, Gi-Won Song, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Sung-Gyu Lee
  Journal of Gastrointestinal Surgery.2021; 25(10): 2503.     CrossRef
• Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
  Hye Yeon Chon, Yeon Seok Seo, Jung il Lee, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, In Hee Kim, Jin-Woo Lee, Young Eun Chon, Moon Young Kim, Soung Won Jeong, Han Ah Lee, Sun Young Yim, Soon Ho Um, Hyun Woong Lee, Kwan Sik Lee, Jeong Eu
  European Journal of Gastroenterology & Hepatology.2021; 33(6): 885.     CrossRef
• Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta‐Analysis
  Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto
  Canadian Journal of Gastroenterology and Hepatology.2021;[Epub]     CrossRef
• Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2021; 13(23): 5892.     CrossRef
• Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study
  Jayoun Lee, Gi‐Ae Kim, Hyo Jeong Kim, Songhee Cho, Min Jung Ko, Young‐Suk Lim
  Journal of Viral Hepatitis.2021; 28(8): 1150.     CrossRef
• Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
  Min Woo Lee, Danbee Kang, Hyo Keun Lim, Juhee Cho, Dong Hyun Sinn, Tae Wook Kang, Kyoung Doo Song, Hyunchul Rhim, Dong Ik Cha, David S. K. Lu
  European Radiology.2020; 30(4): 2391.     CrossRef
• The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
  Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
  Journal of Rheumatic Diseases.2020; 27(1): 4.     CrossRef
• Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
  Gil-Chun Park, Shin Hwang, Myoung-Soo Kim, Dong-Hwan Jung, Gi-Won Song, Kwang-Woong Lee, Jong Man Kim, Jae Geun Lee, Je Ho Ryu, Dong Lak Choi, Hee-Jung Wang, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Young Kyoung You, Koo Jeong Kang, Hee Chul Yu, Yo-Han P
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Treatment and outcomes of extrahepatic malignancy incidentally diagnosed during pretransplant evaluation for living donor liver transplantation
  Gil‐Chun Park, Shin Hwang, Gi‐Won Song, Dong‐Hwan Jung, Deok‐Bog Moon, Chul‐Soo Ahn, Ki‐Hun Kim, Tae‐Yong Ha, Young‐In Yoon, Sung‐Gyu Lee
  Journal of Hepato-Biliary-Pancreatic Sciences.2020; 27(4): 200.     CrossRef
• Is renal replacement therapy necessary in deceased donor liver transplantation candidates with hepatorenal syndrome?: a 2-year experience at a high-volume center
  Gil-Chun Park, Shin Hwang, Dong-Hwan Jung, Gi-Won Song, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Young-In Yoon, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Sang-Hyun Kang, I-Ji Jung, Jin Uk Choi, Sung-Gyu Lee
  Annals of Surgical Treatment and Research.2020; 98(2): 102.     CrossRef
• Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
  Gil-Chun Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Young-In Yoon, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Sang-Hyun Kang, Jin-Uk Choi, I-Ji Jung, Sung-Gyu Lee
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
  Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Hepatology.2020; 71(6): 2023.     CrossRef
• Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment
  Ya‐Chao Tao, Meng‐Lan Wang, Dong‐Mei Zhang, Dong‐Bo Wu, Yong‐Hong Wang, Juan Liao, Hong Tang, En‐Qiang Chen
  Journal of Viral Hepatitis.2020; 27(7): 731.     CrossRef
• Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
  Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
  Clinical and Translational Gastroenterology.2020; 11(3): e00140.     CrossRef
• Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
  Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
  Journal of Gastroenterology and Hepatology.2020; 35(11): 1960.     CrossRef
• Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
  Young Youn Cho, Young Chang, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
  Gut and Liver.2020; 14(2): 225.     CrossRef
• An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well‐controlled viremia
  Hye W. Lee, Soo Y. Park, Myeongjee Lee, Eun J. Lee, Jinae Lee, Seung U. Kim, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Beom K. Kim
  Liver International.2020; 40(7): 1736.     CrossRef
• Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database
  Gil-Chun Park, Shin Hwang, Yo-Han Park, Jin-Uk Choi
  Annals of Surgical Treatment and Research.2020; 98(5): 235.     CrossRef
• Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
  Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  International Journal of Epidemiology.2020; 49(5): 1562.     CrossRef
• Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites?
  Kwang Min Kim, Sang Goon Shim, Dong Hyun Sinn, Jeong Eun Song, Byung Seok Kim, Ho Gak Kim
  Scandinavian Journal of Gastroenterology.2020; 55(8): 951.     CrossRef
• Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
  Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
  Journal of Viral Hepatitis.2020; 27(12): 1306.     CrossRef
• A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
  Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2020; 27(12): 1352.     CrossRef
• Reduced liver cancer mortality with regular clinic follow‐up among patients with chronic hepatitis B: A nationwide cohort study
  Jae‐Jun Shim, Gi‐Ae Kim, Chi Hyuk Oh, Jung Wook Kim, Jisun Myung, Byung‐Ho Kim, In‐Hwan Oh
  Cancer Medicine.2020; 9(20): 7781.     CrossRef
• A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean population
  Jung Yeon Seo, Joong-Gon Shin, Byeong Ju Youn, Suhg Namgoong, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Hyoung Doo Shin, Yoon Jun Kim
  BMC Medical Genetics.2020;[Epub]     CrossRef
• Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease
  Dong Won Park, Yoon Jin Lee, Won Chang, Ji Hoon Park, Kyoung Ho Lee, Young Hoon Kim, Nam Kyu Kang, Jung Wha Chung, Hee Yoon Jang, Soomin Ahn, Haeryoung Kim, Sook-Hyang Jeong, Jin-Wook Kim, Eun Sun Jang, Silvia C. Sookoian
  PLOS ONE.2019; 14(3): e0212771.     CrossRef
• Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
  Joonhong Park, Hanwool Cho, Seung Jun Choi, Gun Dong Lee, Sang Hyun Sin, Ji Hyeong Ryu, Hye-Sun Park, Hyeyoung Lee, Yonggoo Kim, Eun-Jee Oh
  Annals of Laboratory Medicine.2019; 39(1): 86.     CrossRef
• Fibrosis‐matched outcomes between chronic hepatitis B patients with drug‐induced virological response and inactive carriers
  Hye Soo Kim, Oidov Baatarkhuu, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kijun Song, Kwang‐Hyub Han, Beom Kyung Kim, Seung Up Kim
  Liver International.2019; 39(1): 81.     CrossRef
• Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
  Dong-Hwan Jung, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Sung-Gyu Lee
  Annals of Surgery.2019; 269(3): 511.     CrossRef
• Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea
  Jung Hyun Kwon, Myeong Jun Song, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U. Im Chang, Jin Mo Yang, Chan Ran You, Sang Wook Choi, Hae Lim Lee, Sung Won Lee, Nam Ik Han, Soon Woo Nam, Sang Gy
  Digestive Diseases and Sciences.2019; 64(7): 2039.     CrossRef
• Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
  Hye Won Lee, Seung Up Kim, Oidov Baatarkhuu, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
  Scientific Reports.2019;[Epub]     CrossRef
• Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
  Dong Hyun Sinn, Danbee Kang, Minwoong Kang, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  BMC Cancer.2019;[Epub]     CrossRef
• A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea
  Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
  Journal of Hepatology.2019; 71(3): 456.     CrossRef
• Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate
  In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim
  Gut and Liver.2019; 13(1): 93.     CrossRef
• Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
  Mi Na Kim, Seong Gyu Hwang, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Seung Up Kim, Sang Hoon Ahn
  Gut and Liver.2019; 13(2): 197.     CrossRef
• Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles
  Yun Hong, Dongsen Mao, Rui Wu, Zhe Gao, Tingting Meng, Rongrong Wang, Lin Liu, Jing Miao
  RSC Advances.2019; 9(27): 15196.     CrossRef
• High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
  Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
  Alimentary Pharmacology & Therapeutics.2019; 50(2): 215.     CrossRef
• Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
  Jung Hwan Yu, Young Ju Suh, Young-Joo Jin, Nae-Yun Heo, Ji Woong Jang, Chan Ran You, Hyun Young An, Jin-Woo Lee
  European Journal of Gastroenterology & Hepatology.2019; 31(7): 865.     CrossRef
• Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
  Yeonjung Ha, Sohyun Hwang, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
  Journal of Clinical Medicine.2019; 8(5): 656.     CrossRef
• 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  KLCA Korean Liver Cancer Association, NCC National Cancer Center
  Gut and Liver.2019; 13(3): 227.     CrossRef
• External validation of the modified PAGE‐B score in Asian chronic hepatitis B patients receiving antiviral therapy
  Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
  Liver International.2019; 39(9): 1624.     CrossRef
• Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center
  I-Ji Jeong, Shin Hwang, Dong-Hwan Jung, Gi-Won Song, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Ki-Hun Kim, Tae-Yong Ha, Hea-Seon Ha, Jung-Ja Hong, In-Ok Kim, Sung-Gyu Lee
  Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(2): 128.     CrossRef
• 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2019; 20(7): 1042.     CrossRef
• Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
  Hye Won Lee, Seung Up Kim, Jun Yong Park, Oidov Baatarkhuu, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
  Clinical and Translational Gastroenterology.2019; 10(6): e00036.     CrossRef
• Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia
  Tae‐Se Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Journal of Gastroenterology and Hepatology.2019; 34(11): 2028.     CrossRef
• The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria
  Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, Ji Hoon Kim, Moon Seok Choi
  Journal of Viral Hepatitis.2019; 26(12): 1465.     CrossRef
• Stimulated phospholipid synthesis is key for hepatitis B virus replications
  Qingxia Huang, Hehua Lei, Laifeng Ding, Yulan Wang
  Scientific Reports.2019;[Epub]     CrossRef
• Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
  Shin Hwang, Gi-Won Song, Young-Kyu Chung, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Young-In Yoon, Hwui-Dong Cho, Jae-Hyun Kwon, Sang-Hyun Kang, I-Ji Jeong, Jin-Uk Choi, Sung-Gyu Lee
  Journal of Korean Medical Science.2019;[Epub]     CrossRef
• Result Patterns and Characteristics of HBeAg and HBV DNA in Patients with Chronic Hepatitis B
  Eun Jin Choi, Jae Han Kim, Mi-Soon Han
  Laboratory Medicine Online.2019; 9(4): 210.     CrossRef
• Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study
  Chuanmeng Zhang, Jiayuan Wu, Juan Xu, Jie Xu, Jianchun Xian, Shanshan Xue, Jun Ye
  Disease Markers.2019; 2019: 1.     CrossRef
• Natural History and Treatment Indications of Chronic Hepatitis B
  Dong Hyun Sinn
  The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef
• Antiviral drug Utilization and Annual Expenditures for Patients with Chronic HBV Infection in Guangzhou, China, in 2008–2015
  Feng Zhou, Weidong Jia, Shuo Yang, Ge Chen, Guanhai Li, Yueping Li, Yingfang Liang, Yi Yang, Yanhui Gao, Yue Chen
  Antiviral Therapy.2019; 24(6): 405.     CrossRef
• Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma
  Chul‐Soo Ahn, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Sung‐Gyu Lee
  ANZ Journal of Surgery.2018; 88(3): 212.     CrossRef
• Clinico‐pathological correlation of hepatic angiomyolipoma: a series of 23 resection cases
  Dong Hwan Jung, Shin Hwang, Seung Mo Hong, Ki Hun Kim, Chul Soo Ahn, Deok Bog Moon, Abdulwahab A  Alshahrani, Sung Gyu Lee
  ANZ Journal of Surgery.2018;[Epub]     CrossRef
• Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
  Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
  Liver International.2018; 38(1): 68.     CrossRef
• Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
  Mi Young Jeon, Hye Won Lee, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
  Liver International.2018; 38(4): 676.     CrossRef
• Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B
  Jung Gil Park, Yu Rim Lee, Soo Young Park, Heon Ju Lee, Won Young Tak, Young Oh Kweon, Se Young Jang, Jae Min Chun, Young Seok Han, Keun Hur, Hye Won Lee, Min Kyu Kang
  Digestive and Liver Disease.2018; 50(2): 163.     CrossRef
• Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance
  Dong Yun Kim, Hye Won Lee, Jeong Eun Song, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Jun Yong Park
  Journal of Medical Virology.2018; 90(3): 497.     CrossRef
• INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
  Anil Arora, Shivaram P. Singh, Ashish Kumar, Vivek A. Saraswat, Rakesh Aggarwal, Manisha Bangar, Pradip Bhaumik, Harshad Devarbhavi, Radha K. Dhiman, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Dharmesh Kapoor, Kaushal Madan, Jimmy Narayan, Sandeep Nij
  Journal of Clinical and Experimental Hepatology.2018; 8(1): 58.     CrossRef
• Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study
  Shin Hwang, Jae‐Won Joh, Hee Jung Wang, Dong Goo Kim, Kyung Sik Kim, Kyung‐Suk Suh, Seong Hoon Kim, Hee Chul Yu, Chol Kyoon Cho, Young‐Joo Lee, Ki‐Hun Kim, Jong Man Kim, Bong‐Wan Kim, Sung‐Gyu Lee
  World Journal of Surgery.2018; 42(8): 2579.     CrossRef
• A direct role for hepatitis B virus X protein in inducing mitochondrial membrane permeabilization
  H‐R. Lee, Y. Y. Cho, G. Y. Lee, D‐g. You, Y. D. Yoo, Y. J. Kim
  Journal of Viral Hepatitis.2018; 25(4): 412.     CrossRef
• Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
  Heon Ju Lee, Sang Jin Kim, Young Oh Kweon, Soo Young Park, Jeong Heo, Hyun Young Woo, Jae Seok Hwang, Woo Jin Chung, Chang Hyeong Lee, Byung Seok Kim, Jeong Ill Suh, Won Young Tak, Byoung Kuk Jang, Jose Ignacio Herrero
  PLOS ONE.2018; 13(1): e0190581.     CrossRef
• Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population
  Suhg Namgoong, Joong‐Gon Shin, Hyun Sub Cheong, Lyoung Hyo Kim, Ji On Kim, Jung Yeon Seo, Hyoung Doo Shin, Yoon Jun Kim
  Liver International.2018; 38(9): 1576.     CrossRef
• Effect of tenofovir on renal function in patients with chronic hepatitis B
  Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
  Medicine.2018; 97(7): e9756.     CrossRef
• Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
  Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
  Gut and Liver.2018; 12(2): 190.     CrossRef
• Three types of preS1 start codon deletion variants in the natural course of chronic hepatitis B infection
  Won Hyeok Choe, Hong Kim, So‐Young Lee, Yu‐Min Choi, So Young Kwon, Hee Won Moon, Mina Hur, Bum‐Joon Kim
  Journal of Gastroenterology and Hepatology.2018; 33(7): 1370.     CrossRef
• Validation of prognostic scores to predict short‐term mortality in patients with acute‐on‐chronic liver failure
  Do Seon Song, Tae Yeob Kim, Dong Joon Kim, Hee Yeon Kim, Dong Hyun Sinn, Eileen L Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Jae Young Jang, H
  Journal of Gastroenterology and Hepatology.2018; 33(4): 900.     CrossRef
• Serum alanine aminotransferase level and liver‐related mortality in patients with chronic hepatitis B: A large national cohort study
  Jae‐Jun Shim, Jung Wook Kim, Chi Hyuk Oh, Ye‐Rin Lee, Ji Sung Lee, So‐Youn Park, Byung‐Ho Kim, In‐Hwan Oh
  Liver International.2018; 38(10): 1751.     CrossRef
• Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma
  Sang‐Hyun Kang, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Sung‐Gyu Lee
  Journal of Hepato-Biliary-Pancreatic Sciences.2018; 25(4): 240.     CrossRef
• High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
  Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee
  Gut.2018; 67(5): 945.     CrossRef
• Comparison of overall survival between antiviral‐induced viral suppression and inactive phase chronic hepatitis B patients
  Y. Y. Cho, J.‐H. Lee, Y. Chang, J. Y. Nam, H. Cho, D. H. Lee, E. J. Cho, D. H. Lee, S. J. Yu, J. M. Lee, Y. J. Kim, J.‐H. Yoon
  Journal of Viral Hepatitis.2018; 25(10): 1161.     CrossRef
• Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
  H. J. Yim, I. H. Kim, S. J. Suh, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, C. W. Kim, S. Y. Kwon, S. H. Park, M. S. Lee, S. H. Um, K. S. Byun
  Journal of Viral Hepatitis.2018; 25(11): 1321.     CrossRef
• Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
  Jung Hwan Yu, Young‐Joo Jin, Jin‐Woo Lee, Don‐Haeng Lee
  Hepatology Research.2018; 48(11): 862.     CrossRef
• INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
  Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nag
  Journal of Clinical and Experimental Hepatology.2018; 8(4): 403.     CrossRef
• Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
  Dong‐Hwan Jung, Eunyoung Tak, Shin Hwang, Gi‐Won Song, Chul‐Soo Ahn, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gil‐Chun Park, Baek‐Yeol Ryoo, Kyung Jin Lee, Nayoung Kim, Jae‐Hyeon Kwon, Eun‐Kyoung Jwa, Sung‐Gyu Lee
  Liver Transplantation.2018; 24(7): 932.     CrossRef
• Step-down Strategy in Antiviral Resistant Chronic Hepatitis B Patients Who Achieved Viral Suppression With Rescue Combination Therapy
  Dong Yun Kim, Jun Yong Park
  Future Virology.2018; 13(10): 711.     CrossRef
• Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
  Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
  European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447.     CrossRef
• Hepatitis B virus infection and development of chronic kidney disease: a cohort study
  Yun Soo Hong, Seungho Ryu, Yoosoo Chang, Miguel Caínzos-Achirica, Min-Jung Kwon, Di Zhao, Tariq Shafi, Mariana Lazo, Roberto Pastor-Barriuso, Hocheol Shin, Juhee Cho, Eliseo Guallar
  BMC Nephrology.2018;[Epub]     CrossRef
• Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
  Sung Won Chung, Young Chang, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
  Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
• Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas
  Su-Min Ha, Shin Hwang, Jin Young Park, Young-Joo Lee, Ki-Hun Kim, Gi-Won Song, Dong-Hwan Jung, Yun-Suk Yu, Jinpyo Kim, Kyoung-Jin Lee, Eunyoung Tak, Yo-Han Park, Sung-Gyu Lee
  Annals of Surgical Treatment and Research.2018; 95(6): 303.     CrossRef
• Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
  Yong-Kyu Chung, Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Baek-Yeol Ryoo, Sung-Gyu Lee
  Annals of Hepato-Biliary-Pancreatic Surgery.2018; 22(4): 297.     CrossRef
• Tenofovir Disoproxil Fumarate Monotherapy is Superior to Entecavir-Adefovir Combination Therapy in Patients with Suboptimal Response to Lamivudine-Adefovir Therapy for Nucleoside-Resistant HBV: A 96-Week Prospective Multicentre Trial
  Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim, Baek Gyu Jun, Young Don Kim, Dae Won Jun, Joo Hyun Sohn, Tae Yeob Kim, Byung Seok Lee
  Antiviral Therapy.2018; 23(3): 219.     CrossRef
• Durability of the virological response after lamivudine discontinuation in lamivudine‐resistant patients with a complete virological response after lamivudine and adefovir combination therapy
  Mi Na Kim, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Kwang‐Hyub Han
  Journal of Medical Virology.2017; 89(1): 85.     CrossRef
• Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
  S. Lee, S. H. Ahn, K. S. Jung, D. Y. Kim, B. K. Kim, S. U. Kim, O. Baatarkhuu, H. J. Ku, K. Han, J. Y. Park
  Journal of Viral Hepatitis.2017; 24(2): 141.     CrossRef
• Clinicopathological Features and Post‐resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
  Dong‐Hwan Jung, Shin Hwang, Ki‐Hun Kim, Seung‐Mo Hong, Young‐Joo Lee, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Gil‐Chun Park, Eun Sil Yu, Sung‐Gyu Lee
  World Journal of Surgery.2017; 41(3): 825.     CrossRef
• Post‐resection Prognosis of Combined Hepatocellular Carcinoma‐Cholangiocarcinoma According to the 2010 WHO Classification
  Dong‐Hwan Jung, Shin Hwang, Seung‐Mo Hong, Yong‐Kyu Chung, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gil‐Chun Park, Han Chu Lee, Young‐Suk Lim, Eun Sil Yu, Sung‐Gyu Lee
  World Journal of Surgery.2017; 41(5): 1347.     CrossRef
• Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
  Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Hepatology.2017; 66(2): 335.     CrossRef
• Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta‐analysis of prophylaxis management
  Z. Liu, L. Jiang, G. Liang, E. Song, W. Jiang, Y. Zheng, C. Gong
  Journal of Viral Hepatitis.2017; 24(7): 561.     CrossRef
• Reversal of liver cirrhosis: current evidence and expectations
  Young Kul Jung, Hyung Joon Yim
  The Korean Journal of Internal Medicine.2017; 32(2): 213.     CrossRef
• Longterm prognosis of combined hepatocellular carcinoma‐cholangiocarcinoma following liver transplantation and resection
  Dong‐Hwan Jung, Shin Hwang, Gi‐Won Song, Chul‐Soo Ahn, Deok‐Bog Moon, Ki‐Hun Kim, Tae‐Yong Ha, Gil‐Chun Park, Seung‐Mo Hong, Wan‐Jun Kim, Woo‐Hyoung Kang, Seok‐Hwan Kim, Eun Sil Yu, Sung‐Gyu Lee
  Liver Transplantation.2017; 23(3): 330.     CrossRef
• Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
  Young Eun Chon, Jun Yong Park, Sung-Min Myoung, Kyu Sik Jung, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
  American Journal of Gastroenterology.2017; 112(6): 882.     CrossRef
• Rituximab and hepatitis B reactivation in HBsAg-negative/ anti-HBc-positive kidney transplant recipients
  Juhan Lee, Jun Yong Park, Kyu Ha Huh, Beom Seok Kim, Myoung Soo Kim, Soon Il Kim, Sang Hoon Ahn, Yu Seun Kim
  Nephrology Dialysis Transplantation.2017; 32(4): 722.     CrossRef
• Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus
  M. H. Hyun, Y.‐S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon, K. S. Byun
  Alimentary Pharmacology & Therapeutics.2017; 45(12): 1493.     CrossRef
• Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
  Jung Hee Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Journal of Gastroenterology and Hepatology.2017; 32(5): 1100.     CrossRef
• Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
  Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim
  Liver International.2017; 37(12): 1788.     CrossRef
• Prognostic effect of transarterial chemoembolization–induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma
  Woo‐Hyoung Kang, Shin Hwang, Gi‐Won Song, Young‐Joo Lee, Ki‐Hun Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Dong‐Hwan Jung, Gil‐Chun Park, Sung‐Gyu Lee
  Liver Transplantation.2017; 23(6): 781.     CrossRef
• A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
  Dong Hyun Sinn, Jeong-Hoon Lee, Kyunga Kim, Joong Hyun Ahn, Ji Hyeon Lee, Jung Hee Kim, Dong Hyeon Lee, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Gut and Liver.2017; 11(4): 528.     CrossRef
• Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea
  Kyeong Hun Lee, Kyu Seok Shim, In Seok Lim, Soo Ahn Chae, Sin Weon Yun, Na Mi Lee, Young Bae Choi, Dae Yong Yi
  BMC Pediatrics.2017;[Epub]     CrossRef
• Letter: role of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus—authors’ reply
  Y.‐S. Lee, M. H. Hyun, J. H. Kim, J. E. Yeon, K. S. Byun
  Alimentary Pharmacology & Therapeutics.2017; 46(5): 563.     CrossRef
• Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B
  In Du Jeong, Seok Won Jung, Bo Ryung Park, Byung Uk Lee, Jae Ho Park, Byung Gyu Kim, Sung-Jo Bang, Jung Woo Shin, Neung Hwa Park
  Digestive Diseases and Sciences.2017; 62(10): 2908.     CrossRef
• Clinicopathological features and post-resection outcomes of biliary cystadenoma and cystadenocarcinoma of the liver
  Eun-Kyoung Jwa, Shin Hwang
  Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(3): 107.     CrossRef
• Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
  Jihye Park, Kyu Sik Jung, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
  Gut and Liver.2017; 11(6): 828.     CrossRef
• Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Jae Yoon Jeong, Joo Hyun Sohn, Won Sohn, Chan Hyuk Park, Tae Yeob Kim, Dae Won Jun, Yongsoo Kim, Woo Kyoung Jeong
  Gut and Liver.2017; 11(6): 852.     CrossRef
• Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy
  Eun-Jung Park, Kyu-sik Choi, Byung-Cheol Song
  Journal of Rheumatic Diseases.2017; 24(5): 261.     CrossRef
• Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center
  Soo-Min Ha, Shin Hwang, Gi-Won Song, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Ki-Hun Kim, Dae-Yeon Kim, Jungman Namgung, Woo-Hyoung Kang, Seok-Hwan Kim, Eunkyoung Jwa, Jae-Hyeon Kwon, Hui-Dong Cho, Yong-Kyu Jung, Sang-Hyeon
  Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(4): 199.     CrossRef
• Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
  Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, Choon Hyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
  Annals of Surgical Treatment and Research.2017; 93(6): 293.     CrossRef
• Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
  Yeon Seok Seo, Byoung Kuk Jang, Soon Ho Um, Jae Seok Hwang, Kwang-Hyub Han, Sang Gyune Kim, Kwan Sik Lee, Seung Up Kim, Young Seok Kim, Jung Il Lee
  Oncotarget.2017; 8(68): 113213.     CrossRef
• Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
  Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee
  Journal of Gastrointestinal Surgery.2016; 20(11): 1807.     CrossRef
• Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
  Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Digestive Diseases and Sciences.2016; 61(11): 3354.     CrossRef
• Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
  Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
  Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
• The clinical outcomes of chronic hepatitis C in South Korea
  Kyeong Sam Ok, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Si Hyun Bae, Han Chu Lee
  Medicine.2016; 95(35): e4594.     CrossRef
• Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
  Won Sohn, Tae Wook Kang, Sun-Kyu Choi, Sin-Ho Jung, Min Woo Lee, Hyo Keun Lim, Ju-Yeon Cho, Sang Goon Shim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hyunchul Rhim, Yong-Han Paik
  Oncotarget.2016; 7(30): 47794.     CrossRef

Citations

Citations to this article as recorded by  

• Factors associated with hepatitis B mother-to-child transmission in a national prevention program
  Moran Ki, Byung-Woo Kim, Dahye Baik, Jong-Hyun Kim
  Clinical and Molecular Hepatology.2025; 31(4): 1298.     CrossRef
• Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
  Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
• Hepatitis B Virus DNA-Level Change is Associated With Tumor Recurrence in Patients With Resected Hepatitis B Virus Hepatocellular Carcinoma
  Won Tae Cho, Tae Yoo, Jung Min Lee, Jung Woo Lee, Hanbaro Kim, Ji Soo Lee, Sang Hyup Han
  Journal of Surgical Research.2024; 295: 231.     CrossRef
• Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma
  Lanqian Su, Huanyu Luo, Yalan Yan, Zhongqiu Yang, Jiaan Lu, Danqi Xu, Linjuan Du, Jie Liu, Guanhu Yang, Hao Chi
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
  Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
  PLOS ONE.2024; 19(8): e0307712.     CrossRef
• Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
  Ye Ji Jun, Minjong Lee, Ho Soo Chun, Tae Hun Kim
  The Korean Journal of Gastroenterology.2024; 84(5): 206.     CrossRef
• ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis
  Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Se Young Jang, Won Young Tak, Young-Oh Kweon, Soo Young Park, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2023; 21(9): 2278.     CrossRef
• A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features
  Shin Hye Hwang, Seung Baek Hong, Kyunghwa Han, Nieun Seo, Jin‐Young Choi, Jei Hee Lee, Sumi Park, Young‐Suk Lim, Do Young Kim, So Yeon Kim, Mi‐Suk Park
  Journal of Magnetic Resonance Imaging.2022; 55(6): 1877.     CrossRef
• Changes in the Deceased-Donor Trend in Korea: Establishment of Regional Trauma Centers and KODA
  Jeong-Moo Lee
  Journal of Clinical Medicine.2022; 11(5): 1239.     CrossRef
• Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
  Jung Hee Kim, Sung-Eun Kim, Do-Seon Song, Hee-Yeon Kim, Eileen Yoon, Tae-Hyung Kim, Young-Kul Jung, Ki Tae Suk, Baek-Gyu Jun, Hyung-Joon Yim, Jung-Hyun Kwon, Sung-Won Lee, Seong-Hee Kang, Moon-Young Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sang
  Journal of Clinical Medicine.2022; 11(9): 2463.     CrossRef
• Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
  Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim
  Journal of Viral Hepatitis.2021; 28(1): 95.     CrossRef
• Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma
  Hye Yeon Chon, Han Ah Lee, Sang Jun Suh, Jung Il Lee, Byung Seok Kim, In Hee Kim, Chang Hyeong Lee, Byoung Kuk Jang, Hyun Woong Lee, Jae Seok Hwang, Chang Hun Lee, Jin‐Woo Lee, Jung Hwan Yu, Yeon Seok Seo, Hyung Joon Yim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2021; 53(8): 919.     CrossRef
• Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
  Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
  Hepatology International.2021; 15(6): 1328.     CrossRef
• Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis B
  Heechul Nam, Sung Won Lee, Jung Hyun Kwon, Hae Lim Lee, Sun Hong Yoo, Hee Yeon Kim, Do Seon Song, Pil Soo Sung, U Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Nam Ik Han, Jeong Won Jang
  American Journal of Gastroenterology.2021; 116(8): 1657.     CrossRef
• Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
  David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores
  Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim
  European Journal of Gastroenterology & Hepatology.2021; 33(12): 1564.     CrossRef
• Twelve‐month post‐treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B
  Sang Bong Ahn, Jun Choi, Dae Won Jun, Hyunwoo Oh, Eileen L. Yoon, Hyoung Su Kim, Soung Won Jeong, Sung Eun Kim, Jae‐Jun Shim, Yong Kyun Cho, Hyo Young Lee, Sung Won Han, Mindie H. Nguyen
  Liver International.2021; 41(7): 1652.     CrossRef
• Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
  Peter Wigfield, Urbano Sbarigia, Mahmoud Hashim, Talitha Vincken, Bart Heeg
  PharmacoEconomics - Open.2020; 4(3): 403.     CrossRef
• Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
  Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo
  Clinical Gastroenterology and Hepatology.2020; 18(3): 693.     CrossRef
• Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B
  Seung In Seo, Hyoung Su Kim, Bo Kyung Yang, Jin Gu Kang, Woon Geon Shin, Jin Heon Lee, Hak Yang Kim, Myoung Kuk Jang
  Clinics and Research in Hepatology and Gastroenterology.2020; 44(5): 711.     CrossRef
• Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B‐related hepatocellular carcinoma
  Jun Sik Yoon, Hyo Young Lee, Sung Won Chung, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Haeryoung Kim, Jung‐Hwan Yoon, Yoon Jun Kim
  Journal of Gastroenterology and Hepatology.2020; 35(11): 1960.     CrossRef
• Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study
  Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim
  Journal of Gastroenterology and Hepatology.2020; 35(10): 1795.     CrossRef
• A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
  Seung Up Kim, Yong Eun Chon, Yeon Seok Seo, Hye Won Lee, Han Ah Lee, Mi Na Kim, In Kyung Min, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2020; 27(12): 1352.     CrossRef
• Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study
  Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Ju Lee, Hye Jung Shin, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Young Park
  Cancer Epidemiology, Biomarkers & Prevention.2020; 29(4): 832.     CrossRef
• Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
  Hyo‐Sin Kim, Nam‐Joon Yi, Jong Man Kim, Suk Kyun Hong, Choon Hyuck David Kwon, Jae‐Won Joh, Kwang‐Woong Lee, Kyung‐Suk Suh
  ANZ Journal of Surgery.2019; 89(3): 216.     CrossRef
• Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
  Zhihong Liu, Jian Sun, Jinlin Hou
  JAMA Oncology.2019; 5(6): 915.     CrossRef
• Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
  Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
  Liver International.2018; 38(1): 68.     CrossRef
• Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg‐positive high viral load chronic hepatitis B
  J. Y. Nam, Y. Chang, H. Cho, S. H. Kang, Y. Y. Cho, E. J. Cho, J.‐H. Lee, S. J. Yu, J.‐H. Yoon, Y. J. Kim
  Journal of Viral Hepatitis.2018; 25(5): 552.     CrossRef
• Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study
  Yeonghee Eun, In Young Kim, Hyemin Jeong, Hyungjin Kim, Jaejoon Lee, Moon Seok Choi, Eunmi Koh, Hoon-Suk Cha
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study
  Hwi Young Kim, Jeong‐Ju Yoo, Sohee Oh, Su Jong Yu, Yoon Jun Kim, Jung‐Hwan Yoon, Won Kim, Yong Jin Jung, Bo Hyun Kim, Chang‐Min Kim, Joong‐Won Park, Jeong‐Hoon Lee
  Journal of Medical Virology.2018; 90(10): 1593.     CrossRef
• Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area
  Chang Hwi Yoon, Young-Joo Jin, Jin Woo Lee
  European Journal of Gastroenterology & Hepatology.2018; 30(9): 1090.     CrossRef
• Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
  Ji Hyun Kim, Young Don Kim, Minjong Lee, Baek Gyu Jun, Tae Suk Kim, Ki Tae Suk, Seong Hee Kang, Moon Young Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi
  Journal of Hepatology.2018; 69(5): 1066.     CrossRef
• Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
  Baek Gyu Jun, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Seong Hee Kang, Moon Young Kim, Soon Koo Baik, Minjong Lee, Tae-Suk Kim, Dae Hee Choi, Sang-Hyeon Choi, Ki Tae Suk, Dong Joon Kim, Ga
  PLOS ONE.2018; 13(7): e0201316.     CrossRef
• Evaluation of performance characteristics of hepatitis B e antigen serologic assays
  Tonya Mixson-Hayden, Michael A. Purdy, Lilia Ganova-Raeva, Daniel McGovern, Joseph C. Forbi, Saleem Kamili
  Journal of Clinical Virology.2018; 109: 22.     CrossRef
• Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels
  Gang Huang, Peng-peng Li, Wan Yee Lau, Ze-ya Pan, Ling-hao Zhao, Zhen-guang Wang, Meng-chao Wang, Wei-ping Zhou
  Annals of Surgery.2018; 268(6): 943.     CrossRef
• Expression of MMP-9 in different degrees of chronic hepatitis B and its correlation with inflammation
  Yujuan Li, Hongtao Liu, Lixiu Xu
  Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
• HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea
  Chung Hwan Jun, Ban Suk Kim, Chan Young Oak, Du Hyeon Lee, Eunae Cho, Sung Bum Cho, Sung Kyu Choi, Chang Hwan Park, Young Eun Joo, Je-Jung Lee, Hyeoung-Joon Kim
  Hepatology International.2017; 11(1): 87.     CrossRef
• Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
  Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Hepatology.2017; 66(2): 335.     CrossRef
• Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development
  Seung Up Kim, Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Hyon‐Suk Kim
  Liver International.2017; 37(6): 879.     CrossRef
• Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
  Cha Young Kim, Bo Ra Kim, Sang Soo Lee, Dae-Hong Jeon, Chang Min Lee, Wan Soo Kim, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok-Jae Lee
  Medicine.2017; 96(2): e5844.     CrossRef
• Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
  Joon Yeul Nam, Jeong-Hoon Lee, Hwi Young Kim, Jieun E. Kim, Dong Hyeon Lee, Young Chang, Hyeki Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Yuri Cho, EunJu Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Chi-Ling Chen
  PLOS ONE.2017; 12(1): e0166188.     CrossRef
• Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
  Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
  Gut and Liver.2017; 11(1): 129.     CrossRef
• Management of Antiviral Resistance in Chronic Hepatitis B
  Young-Suk Lim
  Gut and Liver.2017; 11(2): 189.     CrossRef
• Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
  Jeong-Hoon Lee, Won Young Tak, Yoon Lee, Min-Kyu Heo, Jae-Sung Song, Hak-Yeop Kim, Soo Young Park, Si Hyun Bae, Joon Hyeok Lee, Jeong Heo, Ki-Hwan Kim, Yong-Soo Bae, Yoon Jun Kim
  OncoImmunology.2017; : e1328335.     CrossRef
• Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer
  Yong Eun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Sojung Han, Mi Young Jeon, Ja Yoon Heo, Kijun Song, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2017; 32(6): 1221.     CrossRef
• A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
  Dong Hyun Sinn, Jeong-Hoon Lee, Kyunga Kim, Joong Hyun Ahn, Ji Hyeon Lee, Jung Hee Kim, Dong Hyeon Lee, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Gut and Liver.2017; 11(4): 528.     CrossRef
• 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
  Chang Hun Lee, In Hee Kim, Jin Chang Moon, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim, Jae Do Yang, Hee Chul Yu
  World Journal of Gastroenterology.2017; 23(2): 297.     CrossRef
• Expression of PBMC apoptosis-related factors in patients with chronic hepatitis B and their relationships with clinical prognosis
  Li Guo, Yanli Liang
  Experimental and Therapeutic Medicine.2017;[Epub]     CrossRef
• Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma
  Tae‐Yong Ha, Shin Hwang, Young‐Joo Lee, Ki‐Hun Kim, Gi‐Young Ko, Dong II Gwon, Chul‐Soo Ahn, Deok‐Bog Moon, Gi‐Won Song, Dong‐Hwan Jung, Han Chu Lee, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jeong‐Heon Choi, Sung‐Gyu Lee
  World Journal of Surgery.2016; 40(5): 1200.     CrossRef
• Hepatocellular Carcinoma Screening and Surveillance
  Changqing Zhao, Mindie H. Nguyen
  Journal of Clinical Gastroenterology.2016; 50(2): 120.     CrossRef
• Outcome of adefovir add‐on lamivudine rescue therapy of up to 5 years in patients with lamivudine‐resistant chronic hepatitis B
  Sung Bae Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han
  Journal of Gastroenterology and Hepatology.2016; 31(1): 241.     CrossRef
• Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
  Yeon Seok Seo, Mi Na Kim, Seung Up Kim, Sang Gyune Kim, Soon Ho Um, Kwang-Hyub Han, Young Seok Kim
  Medicine.2016; 95(12): e2985.     CrossRef
• The Author's Response: Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase
  Junggyu Lee, Dong Hyun Sinn, Seung Woon Paik
  Journal of Korean Medical Science.2016; 31(5): 825.     CrossRef
• A 96‐week randomized trial of switching to entecavir in patients who achieved virological suppression on lamivudine therapy
  Sang Hoon Ahn, Jeong Heo, Jun Yong Park, Hyun Young Woo, Heon Ju Lee, Won Young Tak, Soon Ho Um, Ki Tae Yoon, Soo Young Park, Chang Wook Kim, Hyung Hoi Kim, Kwang‐Hyub Han, Mong Cho
  Journal of Gastroenterology and Hepatology.2016; 31(4): 865.     CrossRef
• Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
  Young-Suk Lim, Kwan Soo Byun, Byung Chul Yoo, So Young Kwon, Yoon Jun Kim, Jihyun An, Han Chu Lee, Yung Sang Lee
  Gut.2016; 65(5): 852.     CrossRef
• Comprehensive outcomes of on‐ and off‐antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis
  Jihyun An, Ju Hyun Shim, Seon‐Ok Kim, Jonggi Choi, Sang‐We Kim, Danbi Lee, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Young‐Hwa Chung, Yung Sang Lee, Dong Jin Suh
  Journal of Medical Virology.2016; 88(9): 1576.     CrossRef
• Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
  Young-Suk Lim, Byung Chul Yoo, Kwan Soo Byun, So Young Kwon, Yoon Jun Kim, Jihyun An, Han Chu Lee, Yung Sang Lee
  Gut.2016; 65(6): 1042.     CrossRef
• Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
  Keol Lee, Dong Hyun Sinn, Geum-Youn Gwak, Hyun Chin Cho, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Gut and Liver.2016; 10(5): 796.     CrossRef
• Consumer's Needs for Development of Smartphone Application for Self Care Performance of Patients with Chronic Hepatitis B
  Jae-Hee Jeon, Kyunghee Kim
  The Journal of the Korea Contents Association.2016; 16(4): 729.     CrossRef
• The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
  Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Liver International.2016; 36(10): 1490.     CrossRef
• Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
  Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn
  Clinical Gastroenterology and Hepatology.2016; 14(11): 1647.     CrossRef
• Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
  Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
  Gut and Liver.2016; 10(5): 818.     CrossRef
• Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
  Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Hyeseung Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Gut and Liver.2016; 10(6): 939.     CrossRef
• Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition
  Tae Yeob Kim, Do Seon Song, Hee Yeon Kim, Dong Hyun Sinn, Eileen L. Yoon, Chang Wook Kim, Young Kul Jung, Ki Tae Suk, Sang Soo Lee, Chang Hyeong Lee, Tae Hun Kim, Jeong Han Kim, Won Hyeok Choe, Hyung Joon Yim, Sung Eun Kim, Soon Koo Baik, Byung Seok Lee,
  PLOS ONE.2016; 11(1): e0146745.     CrossRef
• Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
  Won Sohn, Tae Wook Kang, Sun-Kyu Choi, Sin-Ho Jung, Min Woo Lee, Hyo Keun Lim, Ju-Yeon Cho, Sang Goon Shim, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hyunchul Rhim, Yong-Han Paik
  Oncotarget.2016; 7(30): 47794.     CrossRef
• Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
  Yu Jung Jo, Kyung-Ah Kim, June Sung Lee, Nam-Hoon Kim, Won Ki Bae, Tae June Song, Jeong Wook Kim
  The Korean Journal of Internal Medicine.2015; 30(2): 170.     CrossRef
• Antiviral therapy for chronic hepatitis B in China
  Xin Zheng, Junzhong Wang, Dongliang Yang
  Medical Microbiology and Immunology.2015; 204(1): 115.     CrossRef
• The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients
  Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
  Journal of Gastrointestinal Surgery.2015; 19(7): 1281.     CrossRef
• 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2015; 16(3): 465.     CrossRef
• Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
  Ji Hoon Kim, June Sung Lee
  The Korean Journal of Internal Medicine.2015; 30(1): 23.     CrossRef
• Reimbursement policies in the Asia-Pacific for chronic hepatitis B
  Seng Gee Lim, Deepak N. Amarapurkar, Henry Lik-Yuen Chan, Darrell H. Crawford, Edward J. Gane, Kwang-Hyub Han, Sang Hoon Ahn, Wasim Jafri, Jidong Jia, Jia-Horng Kao, Laurentius A. Lesmana, C. Rinaldi A. Lesmana, Rosmawati Mohamed, Pham Hoang Phiet, Teerha
  Hepatology International.2015; 9(1): 43.     CrossRef
• Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
  Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
  The Korean Journal of Internal Medicine.2015; 30(1): 32.     CrossRef
• Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
  Gi-Ae Kim, Han Chu Lee, Min-Ju Kim, Yeonjung Ha, Eui Ju Park, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim
  Journal of Hepatology.2015; 62(5): 1092.     CrossRef
• Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B
  Mi Sung Park, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Hwan Shin, Wonseok Kang, Chansoo Moon, Kwang‐Hyub Han
  Liver International.2015; 35(2): 455.     CrossRef
• Efficacy of Tenofovir-based Rescue Therapy for Patients with Drug-resistant Chronic Hepatitis B
  Kanghyug Choi, Han Min Lee, Baek Gyu Jun, Sae Hwan Lee, Hong Soo Kim, Sang Gyune Kim, Young Seok Kim, Boo Sung Kim, Soung Won Jeong, Jae Young Jang, Young Don Kim, Gab Jin Cheon
  The Korean Journal of Gastroenterology.2015; 65(1): 35.     CrossRef
• Hepatocellular carcinoma risk in chronic hepatitis B virus–infected compensated cirrhosis patients with low viral load
  Dong Hyun Sinn, Junggyu Lee, Juna Goo, Kyunga Kim, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
  Hepatology.2015; 62(3): 694.     CrossRef
• Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
  Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
  Journal of Korean Medical Science.2015; 30(11): 1618.     CrossRef
• Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma
  Jeong-Heon Choi, Shin Hwang, Young-Joo Lee, Ki-Hun Kim, Gi-Young Ko, Dong Il Gwon, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Sung-Gyu Lee
  Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(2): 59.     CrossRef
• Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
  Hyo Jin Kim, Dong Hyun Sinn, Nam Jun Kim, Jung Hee Kim, Eun Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
  Digestive Diseases and Sciences.2015; 60(12): 3794.     CrossRef
• Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
  Seung Hwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
  Liver International.2015; 35(3): 1054.     CrossRef
• Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance
  Hyo Jung Cho, Soon Sun Kim, Sung Jae Shin, Byung Moo Yoo, Sung Won Cho, Jae Youn Cheong
  Journal of Medical Virology.2015; 87(9): 1532.     CrossRef
• Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy
  Kyu Sik Jung, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Kwang‐Hyub Han
  Hepatology.2015; 62(6): 1757.     CrossRef
• Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
  Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
  Clinical and Molecular Hepatology.2015; 21(1): 24.     CrossRef
• Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
  Jin Chang Moon, Seong Hun Kim, In Hee Kim, Chang Hun Lee, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae-Ghon Kim
  Gut and Liver.2015;[Epub]     CrossRef
• Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
  Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam
  Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
• Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
  Jem Ma Ahn, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Chun-Jen Liu
  PLOS ONE.2015; 10(12): e0144777.     CrossRef
• Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
  Sung Hyun Ahn, Doo Hyun Kim, Ah Ram Lee, Beom Kyung Kim, Yong Kwang Park, Eun-Sook Park, Sang Hoon Ahn, Gu-Choul Shin, Soree Park, Hong Seok Kang, Jin-Kyu Rhee, Sung-Il Yang, Youhoon Chong, Kyun-Hwan Kim, Jason Blackard
  PLOS ONE.2015; 10(8): e0136728.     CrossRef
• Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients
  Ji Won Park
  World Journal of Gastroenterology.2015; 21(13): 3953.     CrossRef
• Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients with a Partial Virological Response
  Hyun Woong Lee, Jae-Cheol Kwon, In Soo Oh, Hye Young Chang, Young Joo Cha, Ik-Seong Choi, Hyung Joon Kim
  Antimicrobial Agents and Chemotherapy.2015; 59(9): 5348.     CrossRef
• Towards the elimination and eradication of hepatitis B
  Geoffrey Dusheiko
  Journal of Virus Eradication.2015; 1(1): 4.     CrossRef
• Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue
  Won Jang, Sung In Yu, Dong Hyun Sinn, Sang Hoon Park, Hyun Park, Ji Young Park, Tae Joo Jeon, Tae Hoon Oh, Won Chang Shin, Won-Choong Choi
  Clinics and Research in Hepatology and Gastroenterology.2014; 38(2): 195.     CrossRef
• High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
  Jong Man Kim, Hyojun Park, Hye Ryoun Jang, Jae Berm Park, Choon Hyuck David Kwon, Wooseong Huh, Joon Hyeok Lee, Sung Joo Kim, Jae-Won Joh
  Annals of Surgical Treatment and Research.2014; 86(5): 256.     CrossRef
• Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
  J.‐H. Cho, J.‐H. Lim, G.‐Y. Park, J.‐S. Kim, Y.‐J. Kang, O. Kwon, J.‐Y. Choi, S.‐H. Park, Y.‐L. Kim, H.‐K. Kim, S. Huh, C.‐D. Kim
  Transplant Infectious Disease.2014; 16(2): 295.     CrossRef
• Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
  Hye Won Lee, Eun Jin Yoo, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
  American Journal of Gastroenterology.2014; 109(8): 1241.     CrossRef
• Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test
  Beom Kyung Kim, Hyon‐Suk Kim, Eun Jin Yoo, Eun Ji Oh, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Seung Up Kim, Young Nyun Park
  Hepatology.2014; 60(6): 1911.     CrossRef
• Long‐term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir
  Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han
  Liver International.2014; 34(8): 1216.     CrossRef
• Preventing Vertical Transmission of Hepatitis B virus
  Won Hyeok Choe, June Sung Lee
  Korean Journal of Medicine.2014; 87(5): 557.     CrossRef
• Oral antiviral agents for treatment of chronic hepatitis B
  Soon Young Ko, Won Hyeok Choe
  Journal of the Korean Medical Association.2014; 57(1): 60.     CrossRef
• Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
  Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
  Clinical and Molecular Hepatology.2014; 20(4): 355.     CrossRef
• Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
  Jae‐Jun Shim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Byung‐Ho Kim
  Journal of Gastroenterology and Hepatology.2014; 29(9): 1699.     CrossRef
• Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
  Keunhee Kang, Ji Hoon Kim
  The Korean Journal of Gastroenterology.2014; 63(5): 329.     CrossRef
• Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea
  A-Jin Lee, Chang Hyeong Lee, Chang-Ho Jeon
  Annals of Laboratory Medicine.2014; 34(3): 230.     CrossRef
• Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
  Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh
  Gastroenterology.2014; 147(1): 152.     CrossRef
• MicroRNA‐196A‐2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B
  Hwi Young Kim, Jung‐Hwan Yoon, Hyo‐Suk Lee, Jae Youn Cheong, Sung Won Cho, Hyoung Doo Shin, Yoon Jun Kim
  Journal of Medical Virology.2014; 86(3): 446.     CrossRef
• Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
  Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
  Clinical and Molecular Hepatology.2014; 20(3): 274.     CrossRef
• Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease
  Mi Sung Park, Kwang-Hyub Han, Seung Up Kim
  Expert Review of Gastroenterology & Hepatology.2014; 8(5): 501.     CrossRef
• The PERFECT Study (PEnnel Real liFe Efficacy Clinical Trial), a Double-Blind, Randomized, Multicenter Trial Examining the Efficacy of Biphenyl Dimethyl Dicarboxylate Combined with Garlic Oil in Patients with Transaminase Elevated Chronic Liver Disease
  Hyung Joon Kim, June Sung Lee, Hyun Woong Lee, Mun Young Kim, Soon Woo Nam, Ju Hyun Sohn, Se Hyun Cho, Seung Gyu Yoon, Jin Mo Yang, Chung Kee Park, Gyu Sung Rim, Young Sok Lee
  Korean Journal of Medicine.2014; 86(2): 179.     CrossRef
• Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital
  Jae Hoon Kim, Ju Seung Kim, Jong Joon Lee, Jung Ho Kim, Suk Young Kim, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
  The Korean Journal of Internal Medicine.2014; 29(3): 307.     CrossRef
• Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy
  Hyun Woong Lee, Hye Young Chang, Suh Yoon Yang, Hyung Joon Kim
  Journal of Clinical Virology.2014; 60(3): 313.     CrossRef
• Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
  Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
  Clinical and Molecular Hepatology.2014; 20(3): 261.     CrossRef
• Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs
  Hyung Rae Sohn, Bo Young Min, Joon Chang Song, Mun Hyuk Seong, Sang Soo Lee, Eun Sun Jang, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
  BMC Infectious Diseases.2014;[Epub]     CrossRef
• Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
  Dong Hyun Sinn, Geum-Youn Gwak, Juhee Cho, Seung Woon Paik, Byung Chul Yoo, Pierre Roques
  PLoS ONE.2014; 9(11): e112184.     CrossRef
• The Impact of the Hepatitis B Virus Polymerase rtA181T Mutation on Replication and Drug Resistance Is Potentially Affected by Overlapping Changes in Surface Gene
  Sung Hyun Ahn, Yong Kwang Park, Eun-Sook Park, Jeong Han Kim, Doo Hyun Kim, Keo-Heun Lim, Moon Sun Jang, Won Hyeok Choe, Soon Young Ko, In-Kyung Sung, So Young Kwon, Kyun-Hwan Kim, G. McFadden
  Journal of Virology.2014; 88(12): 6805.     CrossRef
• Oral Antiviral Therapy for Chronic Hepatitis B Virus Infection: Is Continuous Treatment Needed?
  Chang Hyeong Lee
  Gastroenterology & Hepatology: Open Access.2014;[Epub]     CrossRef
• Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
  Ju-Yeon Cho, Yong-Han Paik, Won Sohn, Hyun Chin Cho, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
  Gut.2014; 63(12): 1943.     CrossRef
• Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
  Hyung Joon Yim, Seong Gyu Hwang
  Clinical and Molecular Hepatology.2013; 19(3): 195.     CrossRef
• Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance
  Dong Hyun Sinn, Jieun Yi, Moon Seok Choi, Dongil Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
  Hepatology International.2013; 7(4): 1010.     CrossRef
• Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
  Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
  Clinical and Molecular Hepatology.2013; 19(3): 273.     CrossRef
• Antiviral Effect of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-associated Myopathy
  Won Young Tak
  The Korean Journal of Gastroenterology.2013; 61(1): 1.     CrossRef
• Occult Hepatitis B Virus Infection: Transmission and Reactivation
  Sang Hee Song, Seong Gyu Hwang
  The Korean Journal of Gastroenterology.2013; 62(3): 148.     CrossRef
• Clinical Efficacy of Entecavir and Factors Predicting Long-Term Treatment Response in Nucleoside-Naïve Patients with Chronic Hepatitis B
  Beom Hee Kim, Beom Yong Yoon, Dae Wha Park, Eaum Seok Lee, Seok Hyun Kim, Byung Seok Lee, Heon Young Lee
  Korean Journal of Medicine.2013; 85(2): 157.     CrossRef
• HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
  Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
  Clinical and Molecular Hepatology.2013; 19(4): 409.     CrossRef
• Continuous Long-Term Entecavir Therapy in Naïve Chronic Hepatitis B Patients Showing Partial Virologic Response
  Dae Hun Kwon, In Hee Kim, Bum Su Choung, Dae Seon Ahn, Sun Ho Yoo, Sang Bae Park, Seok Lee, Seong Hun Kim, Sang Wook Kim, Yong Jin Im
  Gut and Liver.2013; 7(6): 712.     CrossRef